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This paper describes a proactive product stewardship program for glass ﬁbers. That effort included
epidemiological studies of workers, establishment of stringent workplace exposure limits, liaison with
customers on safe use of products and, most importantly, a research program to evaluate the safety of
existing glass ﬁber products and guide development of new even safer products. Chronic inhalation expo-
sure bioassays were conducted with rodents and hamsters. Amosite and crocidolite asbestos produced
respiratory tract cancers as did exposure to ‘‘biopersistent’’ synthetic vitreous ﬁbers. ‘‘less biopersistent’’
glass ﬁbers did not cause respiratory tract cancers. Corollary studies demonstrated the role of slow ﬁber
dissolution rates and biopersistence in cancer induction. These results guided development of safer glass
ﬁber products and have been used in Europe to regulate ﬁbers and by IARC and NTP in classifying ﬁbers.
IARC concluded special purpose ﬁbers and refractory ceramic ﬁbers are ‘‘possibly carcinogenic to
humans’’ and insulation glass wool, continuous glass ﬁlament, rock wool and slag wool are ‘‘not classiﬁ-
able as to their carcinogenicity to human.’’ The NTP’s 12th report on carcinogens lists ‘‘Certain Glass Wool
Fibers (Inhalable)’’ as ‘‘reasonably anticipated to be a human carcinogen.’’ ‘‘Certain’’ in the descriptor
refers to ‘‘biopersistent’’ glass ﬁbers and excludes ‘‘less biopersistent’’ glass ﬁbers.
 2012 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction in the lung and appear to be much less toxic. The adverse effectsAsbestos is a family of naturally occurring ﬁbrous materials
(IOM/NRC, 2009; Lippmann, 2009) historically used as ﬁre retar-
dants, for insulation, and as a ﬁller to strengthen other materials
such as cement products used in building materials and potable
water supply systems. Because some kinds of asbestos are com-
posed of very durable, thin ﬁbers, they are very effective for these
uses. However, certain of the ﬁbers are highly respirable and some
forms (i.e., amphibole asbestos, e.g., amosite, crocidolite) can
persist almost indeﬁnitely in the lung. Thus, inhalation exposure
to certain types of asbestos ﬁbers such as amphibole asbestos
can result in chronic lung inﬂammation, asbestosis (a ﬁbrotic lung
disease), lung cancer and mesothelioma (ATSDR, 2001; Lippmann,
2009). Some forms of asbestos (e.g., chrysotile) are less persistentY-NC-ND license. 
.W. Hesterberg), turbopilot@
), william.bunn@navistar.com
la@turningpointpresentations.
rsh), roger.o.mcclellan@att.netof amphibole asbestos are delayed, not manifesting for 10–40 years
following inhalation exposure. Thus, for many years, the toxic nat-
ure and, especially, the carcinogenic potential of amphibole asbes-
tos was not recognized or well understood. Moreover, because the
asbestos containing materials were so effective in a wide range of
product applications, many kinds of asbestos containing products
were widely used around the world.
Another group of ﬁbers also used for insulation and for other
purposes are synthetic vitreous ﬁbers (SVFs). The SVFs are also re-
ferred to as man-made vitreous ﬁbers (MMVF) or simply as glass
ﬁbers. These synthetic ﬁbers in some cases were used as replace-
ments for various asbestos products. SVFs include inorganic ﬁbrous
substances with an amorphous (vitreous, i.e., non-crystalline)
molecular structure (Hesterberg and Hart, 2001). SVFs can be di-
vided into four general categories: (a) glass ﬁbers (including glass
wool and the thicker glass ﬁlament), (b) special purpose ﬁbers, (c)
mineral wools (rock, stone, and slag wools), and (d) refractory cera-
mic ﬁbers. The four categories of SVFs vary greatly in their toxicity
and potential for causing cancer and other diseases as will be
discussed in this paper. Moreover, the composition and manufac-
turing processes used to produce synthetic ﬁbers can be varied
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properties and, as will be discussed later, minimizing their poten-
tial for posing a health hazard.
Knowledge that exposure to certain kinds of asbestos was
associated with increased occurrence of lung disease and, espe-
cially, the development of mesothelioma which is a rare cancer
triggered a large number of personal injury lawsuits. The
Johns-Manville (J-M) Company, which had emerged as the
world’s leading manufacturer of asbestos-containing products,
was a defendant in many personal injury lawsuits brought by
asbestos exposed workers. The plaintiffs prevailed in numerous
cases and were awarded substantial amounts of damages from
J-M and other defendants. By 1982 J-M determined that its pro-
jected ﬁnancial liabilities, driven by the increase in the number
of claims and the ultimate amount of damages, would eventually
exceed its assets. But it was also apparent that J-M had substan-
tial operating assets that did not involve asbestos products and
that those assets had the potential for serving as the core of an
economically viable company that could continue in business if
the asbestos product lines were discontinued. These factors led
to the decision by J-M in 1982 to enter Chapter 11 bankruptcy
reorganization (Johns Manville, 2010).
As part of the overall reorganization effort, a new company,
Manville Corporation (Manville) was formed. J-M’s asbestos assets
were sold to third parties while J-M’s non-asbestos assets were
transferred to Manville for continuing operation. J-M’s asbestos lia-
bilities were transferred to the Manville Personal Injury Settlement
Trust (PI Trust) or the Manville Property Damage Trust (PD Trust).
The PI Trust was funded largely with J-M insurance proceeds and
80% ownership in the new Manville, which was to be operated
for the beneﬁt of asbestos victims (Manville Trust, 2011).
Under the terms of the reorganization plan, J-M’s commercial
debtors were to be paid in full by Manville and asbestos victims
would receive payment from the PI Trust or PD Trust based on
the severity of their illness or the nature of the property damage.
J-M’s previous shareholders lost as much as 98% of their equity.
In order for those suffering from asbestos-related diseases to be
compensated by the Trust, Manville would have to be proﬁtable.
Accordingly, the building materials part of Manville, turned to syn-
thetic glass ﬁbers to make its insulation products and other special
products. Among the various non-asbestos products of Manville, it
was apparent that its synthetic glass ﬁber production and sales
would be key to Manville’s future long-term survival as a proﬁtable
company. In 1997, Manville changed its name to the current Johns
Manville. The PD Trust was dissolved in the 1990s and in 2001, the
PI Trust sold its stake in Manville to Berkshire Hathaway.
It is important to recognize that other companies with product
lines that included both asbestos and vitreous ﬁbers were in a
similar situation. Indeed, some of those companies also became
bankrupt. Essentially all of them had major reorganizations. Thus,
what is recounted in this paper from the perspective of Manville is
also the saga of other companies with similar product lines. Many
of these companies shared in the ﬁnancial support of much of the
research recounted here primarily working through their trade
associations. Initially, industries primary trade association with
the Thermal Insulation Manufacturers Association and, later the
North American Insulation Manufacturers Association. The scien-
tiﬁc staff of many of those companies were also valuable contribu-
tors to the planning and review of much of this research reviewed
in this paper.2. Are glass ﬁber products safe?
Throughout this paper the words safe and hazardous are used
repeatedly. Safe and hazardous are relative terms at opposite endsof a spectrum. A safe product is a product that when used in accor-
dance with the producer’s recommendations and contemporary
practices has a vanishingly low probability of causing harm. A haz-
ardous product is one that has the potential to cause harm unless
special steps are taken over and above usual consumer or work-
place practices to avoid harm to the user. This paper is in a sense
a saga of creating a body of scientiﬁc knowledge that allows the
marketing and use of safe man-made glass ﬁber products.
Shortly before it emerged from its bankruptcy reorganization, J-
M faced a second potential product liability crisis – the safety of its
glass ﬁber products that would test its commitment to ethical
behavior. The potential safety issue arose over whether glass ﬁber
would be the ‘‘next asbestos,’’ indeed, would synthetic glass ﬁber
be viewed as ‘‘man-made asbestos?’’ In the minds of regulators
and the public, there was concern that exposure to ﬁber glass, be-
cause of its ﬁbrous nature, like asbestos, might cause lung disease.
In the minds of company management, ‘‘the next asbestos’’ had a
different connotation. In the absence of clear and deﬁnitive infor-
mation on the potential health hazards of glass ﬁber, and in light
of J-M’s tarnished reputation, the Company’s products might be
shunned in the marketplace – driving the company out of proﬁt-
ability and possibly into a second bankruptcy (Sells, 1994). In the
absence of a viable ﬁber glass business the company would proba-
bly have had to liquidate its assets.
The harbinger of the product liability concern was a symposium
on synthetic vitreous ﬁbers (SVFs) held in Copenhagen in October
of 1986 under the auspices of the World Health Organization
(WHO, 1986). The symposium was held to review progress in re-
search on the toxicity of all kinds of SVFs, including much of the re-
search that had been sponsored by J-M and other SVF
manufacturers. The symposium also served to provide an update
on information the International Agency for Research on Cancer
(IARC) would use to prepare the next Monograph on the carcino-
genic risks to humans of man-made vitreous ﬁbers (IARC, 1988).
In an overview and summary of the symposium, world-renowned
epidemiologist Sir Richard Doll made this cautious statement,
‘‘If I now abandon the ﬁrm basis of scientiﬁc judgment. . .I do so
because I know that in the absence of such a conclusion, many peo-
ple may think that the whole symposium has been a waste of time.
Let me therefore add. . . accepting that [ﬁber glass and other syn-
thetic vitreous ﬁbers] are not more carcinogenic than asbestos
ﬁbers, we can conclude that exposure to ﬁber levels on the order
of 0.2 respirable ﬁbers per [cubic centimeter] is unlikely to produce
a measurable risk even after another 20 years have passed’’ (Doll,
1987)Doll’s recommendation of a 0.2 ﬁber/cc was the same as the
asbestos personal exposure limit in place in the United States at
that time. While couching his recommendation in tentative lan-
guage, Doll had in effect equated ﬁber glass and asbestos ﬁbers.
Based on worker health data, the scientiﬁc community gener-
ally agreed that ﬁber glass, if it was hazardous to health, was sub-
stantially less so than chrysotile asbestos (Doll, 1987). However,
the mandate of regulatory agencies is to protect workers and the
public. In the absence of compelling evidence to the contrary, these
agencies had little choice but to assume that a substance is harm-
ful. Unfortunately, such a decision has two potential adverse con-
sequences. First, declaring a product hazardous may result in
consumers preferring competing products – even those that have
not been tested at all and may actually be hazardous. Second, con-
sumers may develop ‘‘hazard fatigue.’’ When told that many prod-
ucts are hazardous, consumers may be overwhelmed by the
information and become fatalistic, giving little credence to any
warning. The view of the authors was that Manville’s best strategy
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that products are safe to manufacture and use when appropriate
workplace and use practices are followed. This strategy also recog-
nized the potential for identifying products that had a hazard
potential that would require special approaches to ensure the
safety of workers and consumers.
When Doll made his 0.2 ﬁber/cc recommendation in 1986 for
control of exposures to vitreous ﬁbers, a general understanding
was beginning to emerge that less biopersistant ﬁbers, as mea-
sured by how quickly the ﬁbers dissolve in a simulated body ﬂuid,
were less toxic than highly biopersistent ﬁbers such as amphibole
asbestos. However, it was not known if a biopersistance threshold
existed below which exposure to biosoluble ﬁbers was certain to
not cause lung disease, regardless of dose, dimension or solubility.
In the absence of such a threshold, Doll (1987) and (later) various
hazard identiﬁcation and regulatory agencies, defaulted to recom-
mending that ﬁber glass exposure be limited to the then-current
asbestos standard. It is important to recognize that during that
era momentum was also growing to not just limit exposure to
asbestos but to ban the manufacture and use of asbestos products
based on the fact it was a known human carcinogen.
It was apparent to the companies manufacturing and marketing
glass ﬁber products, and most certainly to J-M, that their already
substantial product stewardship program for glass ﬁbers would
need to be expanded and accelerated. That expanded program in-
cluded continuation of epidemiological studies of ﬁber glass work-
ers, establishment of stringent workplace exposure limits, and
development and implementation of a research program to evalu-
ate the safety of existing ﬁber glass products and guide the devel-
opment of new products. These activities were conducted with
scientiﬁc oversight by industry scientists and external scientiﬁc
consultants. Moreover, regulatory authorities were kept informed
of the research program and provided the opportunity to comment
on protocols before research was initiated. From the beginning, it
was agreed that the research ﬁndings would be presented at scien-
tiﬁc meetings and published in peer reviewed journals.3. State of the science – 1987
As background for considering the new activities of the reorga-
nized J-M Company and other ﬁber glass manufacturers, it is
appropriate to consider in some detail the state of the science on
the toxicity and carcinogenicity of the various man-made vitreous
ﬁbers as it existed in 1987. As will be discussed later, IARC in 1987
used the available science to conduct the ﬁrst in-depth, indepen-
dent evaluation of the human carcinogenic potential for ﬁber glass
with the results of the evaluation published the following year
(IARC, 1988). Moreover, an understanding of the state of the sci-
ence in 1987 provides insight into how the knowledge base on
the toxicity and carcinogenicity of glass ﬁbers could be improved.3.1. Epidemiology studies (pre-1987)
Beginning in 1975, J-M, in cooperation with other manufactur-
ers of ﬁber glass, contracted with researchers at the University of
Pittsburgh, Graduate School of Public Health, Department of Bio-
statistics to conduct a historical cohort study of production and
maintenance workers at 17 of the oldest and largest ﬁber glass
and mineral wool manufacturing facilities in the United States
(Marsh and Enterline, 1977). The main objective of the study was
to evaluate total and cause-speciﬁc mortality risks among those
workers, with primary emphasis on any possible association be-
tween ﬁber exposure and malignant or non-malignant respiratory
disease deaths. The focus of the study was manufacturing where
exposure to glass ﬁbers was viewed as being the highest and cer-tainly much higher than that of users of ﬁber products. There
was a companion study conducted by other researchers (Esmen
et al., 1979) at the University of Pittsburgh to estimate historical
workplace ﬁber exposures. The initial study mainly followed the
mortality from 1946 through 1977 of 16,661 SVF workers em-
ployed one year or more during 1940–1963 (Enterline and Marsh,
1981). The study was updated for the period from 1978 through
1982 and expanded to include a case-referent study to investigate
the possible role of smoking as a confounder biasing the study re-
sults (Enterline et al., 1987). Results from the updated study were
presented at the WHO Symposium in Copenhagen in 1986 and
may have inﬂuenced Sir Richard Doll’s 0.2 ﬁber/cc recommenda-
tion. Enterline et al. (1987), whose research had been funded by
the ﬁberglass industry, reported the 1946–1982 mortality death
rates for workers compared to expected deaths noting there was
a statistically signiﬁcant increase in all malignant neoplasms as a
category and in lung cancer 20 or more years after ﬁrst employ-
ment. For respiratory cancers the excess was greatest for mineral
wool workers. For glass wool workers and glass ﬁlament workers,
the respiratory cancer rates were much lower. There were few po-
sitive relationships between respiratory cancer Standardized Mor-
tality Ratio (SMR) and duration of exposure, time since ﬁrst
exposure or measures of ﬁber exposures. In a case-referent study,
which controlled for smoking, there was a statistically signiﬁcant
relationship between ﬁber exposure and respiratory cancer for
mineral wool workers but not for ﬁber glass workers.
While the University of Pittsburgh cohort mortality studies
were underway, researchers at Tulane University, with support
from the insulating materials manufacturers, were conducting
cross-sectional and follow-up surveys of the respiratory health of
employees of seven of the manufacturing plants included in the
mortality study (Weill et al., 1983; Hughes et al., 1993).
A 1979–1980 survey of the respiratory health of 1028 male pro-
duction workers included respiratory questionnaires, tests of lung
function and readings of chest radiographs in relation to indices of
exposure to man-made vitreous ﬁbers (MMVF). Weill et al. (1983)
reported, ‘‘The study population was found to be generally healthy,
with respiratory symptoms not related to ﬁber exposure and no
detected adverse lung function consequences of that exposure.’’
Furthermore, it was concluded that ‘‘exposure to MMVF with small
diameters may lead to low-level profusion of small opacities. How-
ever, without high-level profusion of these opacities in a popula-
tion with a considerable range of exposure durations, a diffuse
tissue reaction (e.g., ﬁbrosis) seems unlikely but cannot be
excluded.’’
3.2. Laboratory animal studies using implantation (pre-1987)
Prior to 1987, laboratory research on the health effects of ﬁber
glass and other inorganic ﬁbers consisted primarily of studies in
which ﬁbers were placed into the pleural and peritoneal cavities
of rats (Pott and Friedrichs, 1972; Stanton andWrench, 1972; Stan-
ton et al., 1977, 1981) as an alternative to conducting studies using
inhalation exposure. The motivation for conducting those early
studies was largely based on concern for understanding the com-
parative effects of various kinds of asbestos ﬁbers and a desire to
understand which of the ﬁber characteristics, especially diameter
and length, were responsible for asbestos-induced disease. In those
studies, ﬁbers of various compositions and sizes were injected or
implanted into the peritoneal cavity (abdominal intraperitoneal
(IP) injection), the space between the chest wall and the lung sur-
face (pleural space), or instilled into the trachea using a syringe
(intratracheal instillation (IT)). The quantities of material injected
or implanted were quite large, for example, Stanton et al. (1977,
1981) used a standard dose of 40 mg in gelatin pledgets for
implantation into the pleural cavity. The 40 mg of test material
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thoracic cavity of a 70 kg person. To provide perspective, a crocid-
olite asbestos aerosol used in inhalation exposure studies with rats,
to be described later, contained 6.3  108 ﬁbers/m3 when
normalized to 1 mg/m3 (Hesterberg et al., 1996a). Thus, 40 mg of
crocidolite asbestos would contain 2.5  1010 ﬁbers, approximately
one-third would be over 5 lm in length and about 4% over 20 lm in
length. For comparison, the aerosol of one of the SVF products
(MMVF 11) studied contained 1.1  107 ﬁbers/m3when normalized
to 1 mg/m3. Thus, 40 mg of this material would only contain
4.6  108 ﬁbers. Over 70% of the ﬁbers were over 5 lm in length
and more than one-fourth were over 20 lm in length. It is readily
apparent that the quantities of ﬁbers implanted were much greater
than the quantities a rat could inhale during a two-year bioassay.
Many, but not all, of the implantation and injection studies re-
ported an excess of tumors (most of which were diagnosed histop-
athologically as sarcomas) in rats in the asbestos-treated groups
following these types of implantation exposure as well as in some
glass ﬁber treated groups. However, it is noteworthy that 43 out of
72 materials tested by Stanton et al. (1977, 1981) did not yield a
statistically signiﬁcant increase in tumors. This included 16 differ-
ent glass ﬁber preparations. Interpretation of the results of the
early studies focused on the congruence between the ﬁndings of
intra-cavity studies and the emerging epidemiological ﬁndings in
asbestos-exposed workers. Limited attention was given to the glass
ﬁber groups which did not show an excess of tumors despite being
administered large quantities of glass ﬁbers. In short, the intra-cav-
ity study ﬁndings provided a basis for interpreting the importance
of ﬁber dimensions (especially long and thin ﬁbers) in the patho-
genesis of asbestos-induced ﬁbrosis (asbestosis), lung cancer and
mesothelioma.
3.3. Cell studies (pre-1987)
In the 1980’s, numerous laboratories in the US and other coun-
tries were studying the toxicity of various kinds of asbestos ﬁbers
and other ﬁbers in vitro, that is, in cultured cells. Cells were
extracted from the tissues of laboratory animals and grown in cul-
ture dishes. Some cells were treated with chemicals to enhance
their longevity and proliferation in culture and the ability to pro-
duce serial cultures. Other cultures were primary cells that were
taken directly from the animal and, in general, were more difﬁcult
to grow in culture.
As may be recalled, the 1970s and 1980s were a period of major
advances in cell and molecular biology. There was growing enthu-
siasm for using the emerging new techniques for detecting altera-
tions in cells caused by toxic agents and for using the new
approaches to screen new agents for toxic effects. The National
Institute of Environmental Health Science (NIEHS) devoted sub-
stantial resources, both within their intramural and extramural re-
search program, to advance the use of cellular and molecular
approaches to studying genotoxic effects. One of us (TWH) was
at the NIEHS in the early 1980s as a Postdoctoral Fellow at that
time in the laboratory of J.C. Barrett, a well-known cell and molec-
ular biologist, and participated in research on chromosomal muta-
tions and cell transformation in mammalian cells treated with
asbestos ﬁbers and other mineral dusts (Barrett et al., 1983,
1984; Hesterberg and Barrett, 1984, 1985; Hesterberg et al.,
1985, 1986; Oshimura et al., 1984, 1986).
At the time the members of the research team were optimistic
that the results of in vitro studies could identify key events induced
by asbestos ﬁbers that were responsible for the carcinogenic ef-
fects observed in workers exposed to asbestos. It was easy to envi-
sion that the in vitro mutagenicity assays could be used to screen
man-made ﬁbers currently being used or being considered for
introduction to the market place. Short-term assays, such as thewell-known Ames test (Ames et al., 1973) were being greeted with
enthusiasm as an approach to identifying chemicals that were
mutagens, and presumed to be carcinogens. In retrospect, some
of the in vitro research ﬁndings were possibly over-interpreted.
There is no question based on today’s knowledge that the quanti-
ties of asbestos ﬁbers used in many of the in vitro cell studies were
massive when compared to the likelihood of cells encountering
one or several ﬁbers following inhalation exposure. It is also appar-
ent now that the design of the studies could have been improved if
a substantially broader range of exposure (dose) concentrations
had been studied and greater effort had been expended in linking
the dose used in the in vitro studies to in vivo doses actually
encountered by tissues following exposure of people or laboratory
animals to airborne ﬁbers. However, the focus of the research was
primarily on demonstrating and studying effects at the cellular le-
vel, not on understanding exposure (dose)-response relationships.
In the absence of that kind of hindsight, it seemed reasonable in
the 1980s to use the methods that had proved successful with var-
ious kinds of asbestos ﬁbers to study synthetic ﬁbers. In short,
would similar signature effects be observed when cells were
administered synthetic ﬁbers?
3.4. Inhalation studies with glass ﬁbers (pre-1987)
It is important to place a review of pre-1987 inhalation toxicity
studies in experimental animals with glass ﬁbers in context rela-
tive to the overall development of aerosol science and inhalation
toxicology methods for studying all kinds of airborne materials.
Relatively few inhalation studies with laboratory animals had been
conducted pre-World War II and these were typically with gases
and of short duration. The United States Manhattan Project, with
a goal of developing an ‘‘atomic bomb,’’ brought with it concern
for a wide range of airborne particulate materials whose chemical
and/or radiological properties suggested they might pose an inha-
lation hazard.
Thus, an important component of the Manhattan Project was
the development of methods for generating and characterizing air-
borne particulate material and for conducting inhalation toxicity
studies. Much of this work was conducted during and after WW
II at the University of Rochester (U of R), post-WWII at the Hanford
Laboratories (which became the Paciﬁc Northwest Laboratories in
1966) in Richland, WA and, later at the Lovelace organization in
Albuquerque, NM. Sidney Laskin, a key scientiﬁc contributor to
the U of R effect would later play a key role in developing extensive
inhalation toxicology capabilities at New York University.
In the 1960s, a few laboratories began developing the capabili-
ties for conducting lifespan duration inhalation studies with air-
borne particulate material in rodents. Four laboratories that were
at the forefront of this effort were the Lovelace organization, the
Paciﬁc Northwest Laboratories (operated by the Battelle Memorial
Institute beginning in 1965), the Fraunhofer Laboratory in Hano-
ver, Germany and the Battelle Memorial Institute in Geneva, Swit-
zerland. Two other laboratories conducted a few lifespan duration
inhalation studies with airborne particulate material; the Battelle
Memorial Institute Laboratories at Columbus, OH and the Los
Alamos National Laboratory at Los Alamos, NM. Ironically, the Na-
tional Institute of Environmental Sciences, including the National
Toxicology Program, never developed a sustained in-house capa-
bility for conducting lifespan duration studies in rodents with air-
borne particulate material and, instead, contracted with the Paciﬁc
Northwest and Lovelace organization to conduct such studies.
With this as background, it is not surprising that few long-term
inhalation exposure studies with synthetic glass ﬁbers had been
conducted prior to 1987.
Two sets of inhalation toxicity studies with glass ﬁbers con-
ducted in the early 1980s are of special note. One set was
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ratory and the second set was conducted at the Los Alamos Na-
tional Laboratory (LANL) facility in Los Alamos, NM. The Battelle
studies were conducted for the National Institute of Occupational
Safety and Health (NIOSH), the results were detailed in a compre-
hensive report by Mitchell et al. (1982) and summary publications
by Mitchell et al. (1986) and Moorman et al. (1988). These studies
involved inhalation exposures of rats and monkeys to Tempstran
Code 100/475 glass ﬁbers without binder and Owens-Corning FM
series air-ﬁlter media with binder. It is noteworthy that the studies
conducted by Mitchell et al. (1982) and reported by Mitchell et al.
(1986) and Moorman et al. (1988) did not identify an excess of
respiratory tract tumors in the rats exposed to ﬁber glass.
The LANL set of inhalation studies were conducted in the early
1980s with industry support. The results were reported by Smith
et al. (1987) at the 1986 WHO Copenhagen Meeting. The LANL
studies were noteworthy in that they used newly developed tech-
nology for conducting nose-only exposures as contrasted to the
traditional approach of exposing animals group-housed in cham-
bers. Previously, nose-only exposures were typically used for single
or a few brief exposures.
In the LANL study, six different ﬁber types were evaluated (four
of ﬁber glass, one of refractory ceramic ﬁber (RCF), and one of min-
eral wool ﬁber) in rats and hamsters. The ﬁbers used were not size
selected by length and diameter in advance. Instead the ﬁbers were
ground to try to produce a ﬁner aerosol that would be readily inha-
lable by rodents. This resulted in many of the exposure aerosols
having few if any ﬁbers longer than 20 lm in length (the length
that has the greatest pathogenicity due to the inability of the mac-
rophage to fully phagocytise and clear such a ﬁber). In those stud-
ies, none of the four types of ﬁber glass or the mineral wool ﬁber
that were tested caused cancer. However, in the RCF exposure
group, one lung mesothelioma was observed in a hamster; it was
deemed to not be statistically signiﬁcant. However, some scientists
viewed it as a harbinger of what might be observed if the study
were repeated with more animals or in a different species. The sta-
tistically negative results in the Los Alamos study were also ques-
tioned by some observers, because the individual ﬁbers in the
exposure aerosol were on average shorter than the lengths of ﬁbers
typically found in workplace air. This probably occurred as a result
of the aerosol generation process, a Timbrell generator that was
used to generate the aerosol in the study. The Los Alamos difﬁcul-
ties in generating an appropriate aerosol of long ﬁbers served as a
stimulus for developing an improved system that was used in later
studies. It is now well known that ﬁber length is an important
determinant of ﬁber pathogenicity.
Ironically, neither the Battelle–Columbus nor the LANL main-
tained a long-term capability for conducting lifespan duration
inhalation exposure studies with particulate materials. This makes
it difﬁcult to place the results of the studies cited above in context
relative to the results of multiple studies conducted in the same
laboratory with a common protocol as will be described later.
At this juncture, it is appropriate to consider how the epidemi-
ological and laboratory animal data on glass ﬁbers were being used
in 1987 to evaluate potential human hazard.4. Carcinogen classiﬁcation schemes and use of old science
4.1. IARC carcinogenic hazard evaluation (1987–1988)
The ﬁrst in-depth and independent evaluation of the carcino-
genic potential of ﬁber glass was conducted by International
Agency for Research on Cancer (IARC) in 1987 and reported the fol-
lowing year (IARC, 1988). The evaluation of glass ﬁbers was part of
the IARC international, interdisciplinary monograph programdeveloped by IARC (1972) to identify the carcinogenic hazards to
humans from a wide range of agents and exposure conditions.
The IARC reviews are conducted by Working Groups of interna-
tional scientists selected by the Agency for their knowledge of
the agents and/or exposures being evaluated and to provide inter-
national representation. The results of the reviews are reported in
IARC monographs that deal with the ﬁndings for a speciﬁc agent or
condition of human exposure or a series of related agents or expo-
sure conditions. Each IARC Monograph evaluation for an agent or
exposure condition is based on the Working Group’s extensive re-
view and critical analysis of the published peer-reviewed scientiﬁc
literature relevant to evaluating the carcinogenic properties of the
agent or exposure. The Working Group evaluations focus on the
strength of the total evidence for carcinogenicity to humans and
laboratory animals. The IARC classiﬁcation evaluations places an
agent or exposure condition in one of ﬁve groups by combining
evidence for cancer in exposed humans with empirical evidence
for carcinogenicity in laboratory animals and supporting data
(see Table 1). There is no external review process for the IARC
monographs.
The results of the IARC (1988) Monograph evaluation of man-
made ﬁbers are summarized in Table 2. In this evaluation, the re-
sults of intraperitoneal (IP) injection studies in laboratory animals
were given substantial weight. The results of inhalation studies did
not play a major role in the review because the few inhalation
studies that had been conducted pre-1987 were few in number
and had not been designed nor conducted to the rigorous stan-
dards that would be introduced later. As may be noted in Table 2,
the IARC (1988) Monograph categorized man-made ﬁbers into ﬁve
separate categories.
By way of comparison, IARC (1973, 1977, 1987) classiﬁed six
forms of asbestos (actinolite, amosite, anthophyllite, chrysotile,
crocidolite, and tremolite) as ‘‘carcinogenic in humans’’ (Group 1)
based on ‘‘sufﬁcient human evidence.’’ Since the synthetic ﬁbers
were evaluated by some of the same experts that evaluated in
1987 the several kinds of asbestos, it is reasonable to speculate
the ﬁndings with the several kinds of asbestos, and especially the
weight given to the intra-cavitary test results for both asbestos
and man-made ﬁbers, may have inﬂuenced the interpretation of
the signiﬁcance of the intra-cavitary study results as predictors
of the carcinogenicity of synthetic ﬁbers.
4.2. National Toxicology Program report on carcinogens classiﬁcation
The National Toxicology Program (NTP), an organization within
the US Department of Health and Human Services, among its mul-
tiple responsibilities is charged with identifying carcinogenic haz-
ards of various materials under a 1978 Congressional mandate. The
NTP discharges this responsibility by periodically publishing a ‘‘Re-
port on Carcinogens’’ with the ﬁrst one issued in 1980 (NTP, 1980).
The process used by the NTP differs from that used by IARC and
has evolved over the years. The current approach is well docu-
mented (NTP, 2009a,d) and illustrated in Fig. 1. As an initial step,
a Background Document is prepared using the scientiﬁc informa-
tion available on a particular chemical or material. Typically, this
Background Document is prepared by a contractor to the NTP, as
contrasted to the IARC reports which are prepared by participating
scientists with the assistance of the IARC staff. The NTP Background
Documents are made available for public comment and review by
panels of expert scientists appointed by NTP. The NTP classiﬁcation
scheme used to compile the Reports is basically a two-bin system
with agents classiﬁed as either ‘‘known human carcinogen’’ or
‘‘reasonably anticipated to be a human carcinogen.’’ This contrasts
with the ﬁve category scheme of IARC.
In preparing recent reports, the NTP has appointed Expert Pan-
els of scientists knowledgeable of the scientiﬁc information
Table 1
IARC carcinogenic hazard identiﬁcation classiﬁcation scheme.
Group Overall evaluation Strength of evidence
1 Carcinogenic to humans Sufﬁcient evidence of carcinogenicity in humans
2A Probably carcinogenic to humans Limited evidence of carcinogenicity in humans and sufﬁcient evidence of carcinogenicity in experimental animals
2B Possibly carcinogenic to humans Limited evidence in humans in the absence of sufﬁcient evidence in experimental animals
3 Not classiﬁable as to its carcinogenicity to
humans
Agents that do not fall into any other group
4 Probably not carcinogenic to humans Evidence suggesting lack of carcinogenicity in humans together with evidence suggesting lack of carcinogenicity
in experimental animals
IARC (1987), Preamble to IARC Monographs, Supplement 7.
Table 2
IARC evaluation of man-made vitreous ﬁbers (IARC, 1988, 2002b).
Fiber type 1988 2002
Human
evidencea
Animal
evidencea
Overall
evaluationb
Human evidencea Animal
evidencea
Overall
evaluationb
Glass wool Inadequate Sufﬁcient 2B Inadequate Limited 3
Continuous glass ﬁlaments Inadequate Inadequate 3 Inadequate Inadequate 3
Rock (stone) wool Limited Limited 2B Inadequate Limited 3
Slag wool Limited Limited 2B Inadequate Limited 3
Refractory ceramic No Data Sufﬁcient 2B Inadequate Sufﬁcient 2B
Special purpose – – – No comment Sufﬁcient 2B
Newly developed, more biopersistent – – – No human data available No comment No comment
Newly developed, less biopersistent – – – No human data available Commentc Commentc
a Human and animal evidence typically characterized as sufﬁcient, limited or inadequate.
b Overall evaluation: Group 1 – human carcinogen, Group 2A – probable human carcinogen, Group 2B – possible human carcinogen, Group 3 – not classiﬁable, Group 4 –
not likely to be carcinogenic to humans.
c ‘‘The Working Group elected not to make an overall evaluation of the newly developed ﬁbers designed to be less biopersistent. The decision was made in part because no
human data were available, although such ﬁbers that have been tested appear to have low carcinogenic potential in experimental animals and because the Working Group
had difﬁculty in categorizing these ﬁbers into meaningful groups based on chemical composition.’’
Fig. 1. Fiber biopersistance is determined by dissolution, leaching, and fragmentation.
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ground information and on listing/delisting of the substance under
review. The NTP Expert Panel’s recommendations usually carry
substantial weight. However, the report and the Panel’s recom-
mendations are subjected to further review and endorsement (or
rejection) by two review groups of government scientists and ofﬁ-
cials before being ﬁnalized. The ﬁrst of these is the Interagency Sci-
entiﬁc Review Group (ISRG) and the second is the NIEHS/NTP
Scientiﬁc Review Group (NSRG). Both of these Groups, consisting
of government employees, meet in closed sessions and recommenda listing status, a human carcinogen, reasonably anticipated to be a
human carcinogen or not listed. In an additional step, the NTP’s
Board of Scientiﬁc Counselors review and comment on the docu-
mentation and listings. The NTP staff and Director then make a ﬁ-
nal decision on listing or not listing the agent in the next NTP
Report on Carcinogens. The potential also exists for a decision to
delist a chemical or material that was previously listed. If an agent
is listed, brief documentation is prepared for publication in the RoC
summarizing the rationale for the decision. At a ﬁnal stage, the Re-
port is reviewed and approved for release by the Secretary of the
T.W. Hesterberg et al. / Regulatory Toxicology and Pharmacology 62 (2012) 257–277 263Department of Health and Human Services. The current NTP RoC
Review Process (NTP, 2009a) includes as a last step the release of
NTP’s response to the Expert Panel peer review report, the BSC peer
review report, and the public comments.
The 1st Report on Carcinogens prepared by NTP (1980) listed
asbestos as a ‘‘known human carcinogen.’’ The 7th Annual Report
on Carcinogens (NTP, 1994) listed both glass wool (respirable size)
and ceramic ﬁbers (Respirable Size) as substances ‘‘reasonably
anticipated to be a human carcinogen.’’
The preparation of the 7th Report on Carcinogens was carried
out by government scientists with review by the Board of Scien-
tiﬁc Counselors. It did not involve a special Panel of experts as
will be noted for preparation of the 12th Report on Carcinogens
as will be discussed later. Recall that at the time the 7th Report
on Carcinogens was being prepared, the ﬁndings from the sub-
stantial industry research program were just beginning to appear
in the peer-reviewed literature. The insulation glass wool ﬁber
industry had argued during the listing process for the 7th RoC
that the listing criteria were based on obsolete science and on
a classiﬁcation scheme that equates the IARC ‘‘possibly carcino-
genic’’ with the NTP’s ‘‘reasonably anticipated to be a carcino-
gen.’’ The industry commenters did not prevail. The Secretary
of Health and Human Services responded that this listing ‘‘is...
descriptive and represents the initial step in hazard identiﬁca-
tion... It is necessary to conduct a risk assessment in order to
estimate the potential for any substance to harm human health.’’
(NTP, 1994.)5. Multi-faceted path forward in 1987
The IARC (1988) evaluation of man-made vitreous ﬁbers made
clear the importance of having epidemiological evidence available
on the various types of man-made ﬁbers irrespective of whether
the results did or did not show an association between exposure
and increased cancer risk. Thus, it was apparent that extension of
the previous epidemiological studies on workers occupationally
exposed to glass ﬁbers would be an important element of any
on-going product stewardship program for man-made ﬁbers. The
results of this effort are described later.
The IARC review (1988) also demonstrated that the results of
studies conducted in experimental animals, even with inadequate
epidemiological evidence (a term used even if epidemiological
studies have been conducted and do not show a statistically signif-
icant association) could be used to place a speciﬁc ﬁber in Category
2b, ‘‘possibly carcinogenic to humans.’’ The IARC review also dem-
onstrated that in the absence of well-conducted studies using inha-
lation exposure, the normal physiological mode of intake of
airborne ﬁbers, the Review Panel would use data from intra-cavi-
tary implantation or injection studies as positive evidence. It was
apparent in the mid-1980s that some researchers were likely to
continue to conduct intra-cavitary implantation or injection stud-
ies especially because of the ease with which they could be con-
ducted. Thus, it was clear that chronic inhalation studies using
contemporary aerosol science and inhalation toxicology methods
would need to be at the core of any future product stewardship re-
search efforts to evaluate the safety of various types of glass ﬁbers
and that such studies were unlikely to be conducted without
industry support. This program will be described in a later section.
As the inhalation toxicology effort with man-made glass ﬁbers pro-
gressed, it became apparent that substantial attention would need
to be given to understanding the role of biopersistence as a major
factor inﬂuencing the toxicity and, especially, carcinogenicity of
airborne ﬁbers. The research conducted pre-1987 using cellular as-
says provided a rationale for conducting additional studies using
this approach as will be discussed later.5.1. Epidemiological studies (post-1987)
The epidemiology studies, that were underway in 1987 with
sponsorship from the insulationmaterial manufacturers, were con-
tinued and eventually examined the mortality of an enlarged co-
hort of over 32,000 workers (Marsh et al., 2001a, 2001b, 2001c;
Buchanich et al., 2001). The reﬁned protocol included: redoing
and updating work histories; including women for the ﬁrst time;
obtaining information on race; conducting a smoking survey of a
sample of the entire cohort; initiating a new companion investiga-
tion to characterize, in addition to ﬁber exposures, other possible
workplace confounding exposures (e.g., silica and asbestos); a
nested, matched case-control study of respiratory system cancer
deaths in males; and an investigation of mesothelioma in the co-
hort. The epidemiological studies are notable in that they ulti-
mately included nearly a million person years of exposure
extending from 1945 to the early 1990s. Thus, observations were
made over a sufﬁciently long time period that excess cancer would
be detected even if it had a long latency period.
Marsh et al. (2001a, 2001b, 2001c), Buchanich et al. (2001) and
Stone et al. (2001) described the results of the 1986 through 1992
update on the Enterline and Marsh (1981) cohort. This study in-
volved a new historical exposure reconstruction for glass ﬁbers, ar-
senic, asbestos, asphalt, epoxy, formaldehyde, polycyclic aromatic
hydrocarbons, phenolics, silica, styrene and urea. It also included
a nested case-control study of 631 respiratory cases, including
those with smoking histories. The only outcome with a statistically
signiﬁcant excess risk in the updated analysis was respiratory can-
cer. However, the duration of ﬁber and other exposures, the cumu-
lative exposures and the time since ﬁrst exposure were not
associated with cancer risk. Moreover, the smoking habit data indi-
cated that smoking in the exposure cohort was greater than in the
referent population suggesting that at least some of the respiratory
cancer excess were likely due to smoking. One mesothelioma case
was observed in the exposed cohort, while the expected number
based on the referent group was 2.19. Stone et al. (2004) reported
on the risk of respiratory system cancer among female workers in
glass wool plants, RR = 1.02 (95% Conﬁdence Interval, 0.76–1.34),
based on four cases in exposed workers. Marsh et al. (2009) is
the most recent summary of the epidemiological studies of ex-
posed workers.
5.2. Setting the stage for new inhalation studies
By the early 1980s, it was also becoming increasingly accepted
that inhalation exposure studies with well-characterized aerosols
were the most appropriate approach to evaluating human health
hazards for airborne materials in the absence of convincing epide-
miological ﬁndings. During this time period, the Lovelace Inhala-
tion Toxicology Research Institute, which continues today as part
of the Lovelace Respiratory Research Institute in Albuquerque,
NM sponsored a number of workshops to exchange information
between established scientists in the ﬁeld and acquaint new inves-
tigators with contemporary concepts in inhalation toxicology
(McClellan and Henderson, 1989; McClellan, 1995). The Lovelace
inhalation toxicology research program, which was initiated in
the 1960s to study radioactive aerosols, had expanded to consider
other air contaminants such as speciﬁc chemicals and vehicle
emissions and ﬁbers. McClellan (2000a,b) has noted that much of
the momentum for utilizing well-characterized aerosols in re-
search came from the early experience with radioactive aerosols.
The importance of conducting studies using inhalation expo-
sures, as contrasted with non-physiological modes of administer-
ing ﬁbers, was emphasized in the conclusions of multiple
workshops (McClellan et al., 1992; McClellan and Hesterberg,
1994; Vu et al., 1996). McClellan (1995) in reviewing the role of
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emphasized the importance of exposing laboratory rodents via
inhalation to airborne respirable ﬁbers that are comparable in size
to those found in the workplace air. Researchers in the ﬁeld, such
as Hesterberg and Hart (1994) also began to reference data on
workplace exposure (Table 3) which aids in placing the concentra-
tions used in the animal exposure in perspective.
The conduct of large scale inhalation studies with rodents is
expensive and time consuming. One very substantial initial cost,
unique to studies with ﬁbers, relates to the cost of the preparation
of large quantities of size-selected ﬁbers that are rat-respirable
(<1 lm diameter) required to conduct such studies. Thus, a deci-
sion was made for a new series of studies to conduct nose-only
inhalation exposures which require less source material than re-
quired for conducting whole-body exposures (Bernstein et al.,
1995). In addition, the use of nose-only exposures minimizes the
loss of ﬁbers on the pelt of the animals and, thus, minimizes intake
via ingestion as a result of grooming. As an aside, it is important to
recognize that in both laboratory animals and humans some por-
tion of inhaled ﬁbers deposited in the upper airways are cleared
to the oropharynx and ingested. A chronic exposure study involv-
ing exposures 5 days/week for 2 years will involve 500 exposure
days. These studies typically require at least 3 years to conduct
from initiation of detailed planning to completion of the histopa-
thological interpretations and reporting. While inhalation studies
are much more expensive and time-consuming than implanta-
tion/injection studies, they are clearly much more relevant for
assessing the potential health hazards of ﬁbers.
To assist in ensuring the quality of the research, a Science Advi-
sory Group (SAG) was convened by J-M to help design the SVF re-
search program, to provide oversight of the research and to aid in
interpretation of the results. Members of the group were respected
independent experts in the ﬁelds of medicine, veterinary medicine,
public health, toxicology, epidemiology, aerosol science, industrial
hygiene, and statistics. One of the authors (Roger O. McClellan)
served as a member of the SAG. The results of the studies, as they
became available, were shared with the scientiﬁc community, reg-
ulators, and the public. The results of the studies were also pre-
sented at scientiﬁc meetings and published in peer-reviewed
scientiﬁc journals.
Each of the serious limitations in the pre-1987 studies was ad-
dressed in the new inhalation exposure study protocols. The limi-
tations of the earlier studies included: use of test ﬁbers with
diameters too large to be readily inspired into the deep lung and/
or were too short to have unique carcinogenic properties; inade-
quate characterization of ﬁber numbers and dimensions in expo-
sure aerosols and/or inadequate reportings; lack of measurement
of the burden of ﬁbers in the lungs, and the absence of a determi-
nation of whether the Maximum Tolerated Dose (MTD) had been
attained. The MTD is highest daily dose that does not cause overtTable 3
Comparison of ﬁber exposures: human experience versus rat inhalation study
concentrations. Adapted from: Hesterberg and Hart (1994).
Environment Product Fibers/cm3
Human
Outdoor Fibers related to existing insulation 0.0007
Indoor Air Fiber glass batt insulation, prior to installation 0.00005
Manufacturing Fiber glass wool insulation 0.065
Installation Fiber glass batts 0.09
Blowing ﬁber glass 7.67
Removal Ceiling and pipe insulation 0.04
Rat
Inhalation studies MMVF-10, MMVF-11 239toxicity in a ninety-day laboratory study and is typically used in
chronic exposure studies to maximize the likelihood of detecting
any toxic effect including cancer (McConnell, 1996).
To evaluate the potential for the material to cause health effects
of any kind, speciﬁcally tumor induction, it is desirable in design-
ing chronic inhalation exposure studies to include on multiple
exposure levels with the highest exposure concentration selected
to maximize the potential for detecting an excess of effects over
that observed in controls. At the same time, it is desirable to avoid
having an exposure level that is so high that non-speciﬁc toxic ef-
fects are produced that may interfere with the detection of test
agent speciﬁc effects. Selection of the appropriate highest exposure
level is always challenging (Lewis et al., 1989; McClellan et al.,
1992; Hesterberg et al., 1999).
The issue of conducting studies with aerosol exposures that
might exceed the MTD came to the forefront in the 1980s with
the observation of a high incidence of lung tumors in rats exposed
to materials that were not genotoxic or were suspected of having
low genotoxic potency. Of special note were ﬁndings frommultiple
studies conducted with whole diesel exhaust in which an excess of
lung tumors was observed in rats, but not in mice, exposed to the
same test atmosphere (Mauderly et al., 1987, 1996; Hesterberg
et al., 2005; Mauderly and Garshick, 2009). Detailed studies on
the deposition and retention of the diesel soot (carbonaceous par-
ticles and associated hydrocarbons) demonstrated that the reten-
tion of the inhaled particles was altered when the rats were
exposed to high concentrations of particles (up to 7 mg/m3, 7 h/
day, 5 days/week) for extended periods of time (Wolff et al.,
1987). The resulting ‘‘lung over-load’’ led to a cascade of events
including inﬂammation, cell proliferation, mutations, and ulti-
mately, lung cancer. It is noteworthy that similar ﬁndings were ob-
served with carbon black, which is free of any direct acting
mutagenic chemicals, indicating that the effect observed with die-
sel exhaust particulates was not the result of direct acting muta-
gens associated with the particles (Nikula et al., 1995). Driscoll
et al. (1996) provided data on mutation induction related to parti-
cle burdens of Carbon Black that provided a basis for mechanistic
interpretation of the ﬁndings of Nikula and colleagues. It soon be-
came apparent that the development of lung tumors in rats associ-
ated with large lung burdens was a non-speciﬁc effect observed
with many kinds of inhaled particles (Warheit et al., 1997). The Na-
tional Toxicology Program, recognizing that the issue of ‘‘lung
overload’’ was of broad concern, convened a special Panel to offer
advice on setting aerosol exposure concentrations for inhalation
toxicity studies so as to avoid the non-speciﬁc pulmonary effects
(Lewis et al., 1989).
An awareness of the experience with ‘‘lung overload’’ and ‘‘max-
imum tolerated dose’’ (more correctly, maximum tolerated expo-
sure) with non-ﬁbrous aerosols stimulated special concern for
these issues in planning the new generation of ﬁber inhalation
studies (Hesterberg et al., 1996b). The planning and conduct of
the new ﬁber studies included the following advances:
(a) Use of size-separated ﬁbers. It is now well known that ﬁber
length and diameter are critical determinants of the toxicity
of durable ﬁbers—longer ﬁbers (greater than 15 lm) were
more toxic, while thinner ﬁbers (less than 2 lm in diameter)
were more respirable. Indeed, particles (including ﬁbers as a
special form of particle) with an aerodynamic size of 3
micron or greater have a very low probability of being
inhaled and reaching the alveolar region (Schlesinger,
1995; McClellan, 2000a,b). Some earlier chronic inhalation
studies were conducted using relatively short test ﬁbers
and/or ﬁbers that were too thick to have a substantial por-
tion of the ﬁbers inhaled and deposited in the lungs. Thicker
ﬁbers deposit predominantly in the upper respiratory tract
T.W. Hesterberg et al. / Regulatory Toxicology and Pharmacology 62 (2012) 257–277 265with, at best, only a small portion reaching what is viewed
as the more vulnerable deep lung. Typically, the vast
majority of ﬁbers in glass wool insulation are too thick
and long to be readily respirable. Techniques were devel-
oped to break the glass ﬁbers and then selectively separate
out the longer thinner ﬁbers. Thus, the ﬁbers prepared for
use in the inhalation studies represented only a portion of
the total mass, a portion thought to have the highest
potential for producing effects. Thus, it was anticipated that
the inhalation studies would represent a ‘‘worse’’ case situ-
ation relative to exposures in manufacturing facilities or by
a user. Fibers observed in sampling workplace air were
found to typically have an average diameter of 1 lm and
an average length of 20 lm. Thus, techniques were devel-
oped to select ﬁbers with these dimensions and prepare
large quantities for use in animal exposure studies. The size
selection techniques were innovative and used to prepare
reproducible and consistent ﬁber sizes for a number of dif-
ferent ﬁber glasses and other synthetic vitreous ﬁber com-
positions. Thus, it was possible to compare the pulmonary
effects of the various different ﬁber compositions in rats
exposed by inhalation while minimizing the confounding
variables of ﬁber length and diameter (Hesterberg et al.,
1993).
(b) The average ﬁber diameter observed in the work place was
similar to the diameter of ﬁbers which would be respirable
in the rat. Thus, techniques were developed to select ﬁbers
with similar dimensions and prepare large quantities for
use in animal exposure studies. The size selection tech-
niques were highly innovative and produced consistent ﬁber
sizes for a number of different ﬁber glasses and other syn-
thetic vitreous ﬁber compositions. Thus, it was possible to
compare the lung effects of the various different ﬁber com-
positions in rats exposed by inhalation while minimizing
the confounding variables of ﬁber length and diameter
(Hesterberg et al., 1993). The likelihood of inhaled ﬁbers
transiting the branched and narrow conducting airways of
the respiratory tract and reaching the deep lung is deter-
mined by the inertial properties of the ﬁbers. The inertial
property of particles of different shapes and densities is
characterized by their ‘‘aerodynamic diameter,’’ a compari-
son of their inertial properties to that of a spherical particle
having a density of 1 g/cm3. Thus, it is important to charac-
terize the aerosol of ﬁbers as to their aerodynamic diameter
along with ﬁber number and physical dimensions. The aero-
dynamic diameter is an important parameter to evaluate
since the likelihood of a ﬁber being inhaled and deposited
in the respiratory tract is primarily determined by its aero-
dynamic diameter. In planning and interpreting the studies
with rats, it was recognized that this species is an obligate
nose breather as contrasted with humans who breathe
through both their nose and mouth.
(c) The development of aerosol generation systems which do
not break or grind the ﬁbers. Most early inhalation toxicol-
ogy studies with ﬁbers had used the Timbrell aerosol gener-
ator or similar devices for the aerosolization of ﬁbers, recall
the LANL studies reported by Smith et al., 1987. This device
required the ﬁbers to be compressed into a plug, a rotating
steel blade scraped ﬁbers off the plug into the air stream.
This process reduced the length of some ﬁbers and, in addi-
tion, added metal contaminants from the scraping surface
into the ﬁber air stream. To avoid these problems and to
be able to aerosolize the bulk ﬁbers without altering their
characteristics or dimensions, a new aerosol generation
device was developed using a rotating brush feed system
(Bernstein et al., 1994, 1995).(d) Quantitative reporting of ﬁber numbers and dimensions in
aerosols. The methods used allowed the aerosols to be char-
acterized in units of ﬁbers/cc of air as well as more typical
measures of particle mass reported in units of mg/m3. In
addition, the bivariate diameter and length of ﬁbers in both
the aerosol and in the lung was routinely characterized in
the studies.
(e) Lung burdens. Techniques were developed to characterize
the lung burden of ﬁbers as to their number and ﬁber
dimension. This allowed results to be analyzed not only with
regard to exposure concentration as was traditional, but
with regard to lung burden. This facilitated the evaluation
of the deposition and clearance of the inhaled ﬁbers and,
ultimately, a comparison of various kinds of ﬁbers based
on their biopersistence
5.3. Industry-sponsored chronic inhalation studies (post-1987)
The studies sponsored by the Thermal Insulation Manufac-
turer’s Association, and later, the North American Insulation
Manufacturers Association were conducted by the Research and
Consulting Company (RCC), a Swiss ﬁrm, over a period of ten years.
The studies were initially conducted in the facilities and with
equipment and procedures developed by Battelle-Geneva under
the direction of one of the authors of this paper (DMB). Later, the
operations were moved to RCC facilities at Itengen, Switzerland.
The studies conducted under contract by RCC were at the core of
the ﬁber glass industry’s product stewardship program. The cost
of the studies exceeded over $30 million (in 1990 dollars).
At the time these studies were planned, it was well recognized
that certain types of asbestos were carcinogenic in humans based
on epidemiological evidence (IARC, 1987). Animal studies with
asbestos were clearly not needed to bolster this conclusion. How-
ever, it was recognized that well-conducted inhalation studies
with asbestos ﬁbers known to be carcinogenic to humans were re-
quired to validate the experimental animal protocol being used to
evaluate the carcinogenic potential of the synthetic ﬁbers. Thus,
the core program included ‘‘positive control’’ groups exposed to
Amosite or Crocidolite asbestos, anticipating that these ﬁbers
known to be human carcinogens based on epidemiological evi-
dence would produce an excess of tumors in laboratory animals.
A total of nine different synthetic ﬁber types were studied (Ta-
ble 4) (Bernstein et al., 1996, 1997; Davis et al., 1996; Hesterberg
et al., 1993, 1997, 1998a, 1998b, 1999; Hesterberg and Hart,
2001; Kamstrup et al., 1996; Mast et al., 1995a, 1995b; McConnell
et al., 1994, 1999). The United States Environmental Protection
Agency (US EPA) and the Occupational Safety and Health Adminis-
tration (OSHA) were invited to comment on the study protocols be-
fore the studies were initiated to encourage the use of the results
for regulatory purposes, irrespective of whether an excess of tu-
mors were or were not observed. These agencies were also pro-
vided with the interim study results as they became available
and, of course, the agencies received the ﬁnal reports and pub-
lished papers.
The basic protocol for the chronic studies, to evaluate carcino-
genic potential, involved nose-only exposure (6 h/day, 5 days/
week) of rats and Syrian hamsters for up to two years with animals
monitored for the rest of their lives (Bernstein et al., 1995). Rats
were selected for use as the rat had been shown to be the most ro-
bust laboratory animal for inhalation studies with airborne partic-
ulate materials. Syrian hamsters were also used primarily because
they had been used in the earlier industry studies conducted at the
Los Alamos National Laboratory in the 1980s. Moreover, during
that time period Syrian hamsters were being used increasingly in
inhalation studies with airborne particulate materials. Mice were
not considered appropriate for use in these studies recognizing
Table 4
Lung deposition, biopersistence, and in vitro dissolution of SVFs correlated with lung pathogenicity.a
Fiber Type Lung depositionb Lung clearance In vitro dissolution Pathogenicity References
F/L  106 ± st. dev F > 20 lm pH 7 pH 4.5 Chronic inhalation
F/L > 5 lm F/L > 20 lm WT1/2c (days) Kdisd Kleache Fibrosis Tumors
Amosite Asbestos 10.9 ± 1.0 1.6 ± 0.3 418 <1 Ndf + + McConnell et al. (1994)
Crocidolite Asbestos 29.8 ± 7.1 1.0 ± 1.0 817 <1 nd + + McConnell et al. (1994)
MMVF32 Special Purpose E Glass 5.7 ± 1.3 1.3 ± 0.3 79 9 7 + + Davis et al. (1996)
RCF1ag Refractory 8.3 ± 2.0 1.5 ± 0.2 55 3 nd + + Mast et al. (1995a)
MMVF33 Special Purpose 475 Glass 7.1 ± 0.6 1.4 ± 0.3 49 12 13 + ±h McConnell et al. (1999)
MMVF21 Rock Wool 7.7 ± 1.0 1.1 ± 0.1 67 20 72 +  McConnell et al. (1994)
MMVF10 Insulation Glass Wool 8.6 ± 1.6 1.0 ± 0.2 14.5i 300 329   Hesterberg et al. (1993)
X607e Hybrid SVF 3.6 nd 9.8 990 nd   Hesterberg et al. (1998a,b)
MMVF11 Insulation Glass Wool 5.6 ± 1.2 1.0 ± 0.2 9 100 25   Hesterberg et al. (1993)
MMVF22 Slag Wool 3.4 ± 0.6 0.4 ± 0.1 9 400 459   McConnell et al. (1994)
MMVF34 Stonewool 9.1 ± 1.7 1.5 ± 0.4 6 59 1010   Kamstrup et al. (1998)
a Table from Hesterberg and Hart, 2001 and Hesterberg et al., 1998b.
b Details of ﬁber classiﬁcation are contained in the papers referenced in footnote a.
c WT1/2, weighted clearance half-time in days.
d kdis (dissolution rate, kdis = ng/cm2 h) values for MMVF34 from Kamstrup et al. (1998); others from Eastes and Hadley (1996). Kdis values may differ from those published
elsewhere due to varying methodologies.
e kleach dissolution rate constant of leaching elements represented by Ca and Mg at pH 4.5 (rounded up to whole numbers). Source: Guldberg et al. (1998).
f nd, not done.
g RCF1 was used in pathogenicity studies. RCF1a was modiﬁed from RCF1 to contain fewer non-ﬁbrous particles.
h ± indicates tumorigenicity in hamsters (one mesothelioma in 83 animals) but not in rats.
i Clearance half-time of 14.5 days was determined using a modiﬁed MMVF10 test ﬁber that had been size-selected to have longer and thinner average dimensions than the
original MMVF10.
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bound of the size of particles that mice can inspire (Snipes, 1989).
The ﬁber aerosols were produced using a special aerosol gener-
ation system developed at Battelle-Geneva and RCC (Hesterberg
et al., 1993; Bernstein et al., 1994, 1995). The animals were ex-
posed nose-only in a special exposure system that had originally
been developed at the Paciﬁc Northwest Laboratories (Cannon
et al., 1983), the system provided for continuous laminar ﬂow of
the contaminated air past the nose of each animal restrained with-
in its own exposure tube and with exhaled air diverted so it did not
reach other animals being exposed concurrently. The ﬁber concen-
trations were monitored continuously with a light-scattering
instrument. Direct ﬁber mass measurements were made on sam-
ples collected with membrane ﬁlters. In addition, samples were
collected periodically for electron microscopic determination of ﬁ-
ber dimensions. The target aerosol concentrations for the ﬁber
glass exposure groups were 3, 16 and 30 mg/m3 with concurrent
controls exposed to clean air.
A number of health indicators were routinely evaluated. Special
care was taken to conduct detailed gross and histopathological
evaluations of the respiratory tract. From Table 4, it is apparent
that the amosite and crocidolite exposed groups developed an ex-
cess of respiratory tract tumors as expected. In addition, it is appar-
ent that an excess of respiratory tract tumors were observed in the
Groups exposed to MMVF32, (a special purpose glass ﬁber) and the
RCF1a, (a refractory ceramic ﬁber). One mesothelioma (in 83 Syrian
hamsters) was observed in the MMVF33 (a special purpose glass ﬁ-
ber) Group. Five Groups (MMVF10, X607, MMVF11, MMVF22, and
MMVF34) did not have an excess of respiratory tract tumors. These
Groups had all been exposed to more soluble ﬁbers that were sub-
stantially less biopersistent than the amosite and crocidolite ﬁber
and the special purpose ﬁbers.
Sub-groups of animals were periodically killed and their lungs
taken for determination of the ﬁber burden (Hesterberg et al.,
1996b). The lungs were dried and plasma ashed to provide speci-
mens for quantiﬁcation of the lung burdens of ﬁbers and determi-
nation of ﬁber dimensions.
From the results of chronic exposure studies, it soon became
clear that ‘‘biopersistence’’ was the key determinant of the toxicity
of a synthetic vitreous ﬁber (Bernstein et al., 1994; Hesterberget al., 1996b). Biopersistence refers to the ability of ﬁbers to persist
in the lung over time. In the chronic studies, the ﬁve types of syn-
thetic vitreous insulation ﬁbers that had low biopersistence, did
not cause lung ﬁbrosis or tumors even when laboratory animals
were exposed to high concentrations of long, respirable ﬁbers.
One synthetic rock wool ﬁber type produced ﬁbrosis, however, it
did not produce tumors. The statistically signiﬁcant positive tumor
ﬁndings in the two asbestos groups (amosite and crocidolite) and
two of the synthetic ﬁber groups (Special Purpose E Glass and
Refractory Ceramic Fiber) validated the bioassay as being capable
of detecting tumorgenic activity. The observation that the two syn-
thetic ﬁbers that were biopersistent produced an excess of lung tu-
mors motivated the ﬁber industry to initiate additional
experiments to gain a better understanding of the importance of
the biopersistence in determining the lung disease causing poten-
tial of SVFs.
5.4. Short-term animal biopersistence studies
In the chronic inhalation studies, ﬁber biopersistence, which is
inﬂuenced by chemical composition and manufacturing mode,
emerged as an important determinant of ﬁber pathogenicity. Fiber
dissolution is a measure of how quickly a ﬁber dissolves in a sim-
ulated body ﬂuid in a test tube (in vitro). It was hypothesized that
ﬁber dissolution rates could serve as a surrogate for the more rel-
evant parameter, biopersistence in the lung (Bernstein et al., 1994;
Hesterberg et al., 1998a,b; Hesterberg and Hart, 2000). In vivo biop-
ersistence studies measures how long ﬁbers persist in the lungs
after being deposited. Some ﬁbers crumble (break transversely)
and/or dissolve relatively quickly in the lung environment, while
other ﬁber types persist for longer periods of time or even appear
to be indeﬁnitely retained (see Fig. 2).
In order to understand the actual fate of inhaled ﬁbers in the
lung, protocols were developed for measuring biopersistence of ﬁ-
bers in the rat lung (Bernstein et al., 1994; Hesterberg et al., 1996a;
Hesterberg and Hart, 2001). These studies were designed to evalu-
ate the number and dimensions of ﬁbers retained in the lung over
time. In the biopersistence studies, rats were exposed by nose-only
inhalation techniques for ﬁve days, 6 h per day to aliquots of the
same ﬁbers used in the chronic studies (nine different SVFs and
Fig. 2. Retention of ﬁbers after 5 days of exposure (6 h/day). Fig. 3A (top) – Crocidolite, Fig. 3B (bottom) – Fiber Glass Wool (MMVF11). The fraction of ﬁbers retained is shown
for four different ﬁber length-categories. Fiber lengths in microns.
Fig. 3. (A) Crocidolite asbestos. (B) Fiber glass wool (MMVF11).
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exposure of animals for 30 h to an aerosol of the test ﬁber assured
that the lung burden of ﬁbers would be sufﬁciently large that the
decrease in lung burden could be followed for some time.
At several time points up to one year after exposure, the lung
burdens of ﬁbers were evaluated. The results of lung burden biop-
ersistence for crocidolite and MMVF-11 (Insulation Glass Wool)
groups exposed for ﬁve days is shown in Fig. 2. The long-term biop-
ersistence of the crocidolite ﬁbers is very apparent. In particular,
note the substantial fraction of the crocidolite ﬁbers (over 5 lm,
over 10 lm and over 20 lm in length) that were retained for up
to a year after cessation of exposure. Over one-half of the crocido-
lite ﬁbers over 20 lm in length were present at one year after ini-
tiation of the exposures. In contrast, with the MMVF-11, ﬁbers, an
insulation glass wool, only a small fraction of the material was
present in the lungs one year after 5 days of exposure. There were
essentially no glass ﬁbers longer than 10 lm in length retained
after six months.
Different ﬁber types were compared based on how long it took
to clear half of the original ﬁbers from the lung. A metric, the
weighted lung clearance half-time (WT1/2), which took into ac-
count both the trachea–bronchial clearance and the deep-lung
clearance of ﬁbers, was developed to compare the clearance rates
of different ﬁber types from the lung. Based on this work, it was
found that the single parameter, WT1/2, correlated very well with
the chronic toxicity produced by the ﬁbers (Table 4).
As presented above, the relationship between biopersistence
and chronic toxicity was considered sufﬁciently strong (Bernstein
et al., 2001a, 2001b) that the European Commission incorporated
both biopersistence and chronic toxicity evaluations as criteria
for the exoneration of the ﬁbers as a carcinogen (Commission
Directive 97/69/EC of 5 December 1997) as will be discussed later.
In order to facilitate the limitation of these tests for the Commis-
sion Directive, detailed protocols were established by the European
commission (Bernstein and Riego-Sintes, 1999). In addition, a pro-
tocol was developed and included in this set for this sub chronic
inhalation toxicity (90 days) evaluation for ﬁbers. These protocols
have become the de facto standard for evaluating either the biop-
ersistence or the chronic toxicity of ﬁbers and the potential for the
synthetic ﬁbers to cause cancer.
These biopersistence studies were critical to understanding
why some ﬁbers produce pathogenic changes and others do not.
A major goal of the research effort was to determine if the results
of short-term biopersistance tests were a valid predictor of long-
term toxicity and carcinogenicity. It was anticipated that if the
short-term test could be validated as a predictor of long-term tox-
icity, it would certainly justify the substantial expense of conduct-
ing the validation studies. Without question, biopersistence
studies cost less money, require fewer animals, and can be com-
pleted within a few months, compared to lifetime chronic carcino-
genicity studies, which costs millions of dollars, utilize hundreds of
animals, and take several years to complete (Hesterberg and Hart,
2001). The need to use fewer laboratory animals is a beneﬁt rela-
tive to Animal Welfare considerations. Moreover, the quick turn-
around time associated with short-term tests was viewed as
advantageous for the development of new ﬁbers for introduction
into the marketplace.
5.5. In vitro ﬁber dissolution studies
In vitro ﬁber dissolution was another ﬁeld in which major con-
tributions were made by researchers at J-M and in other ﬁber
industry laboratories. In these studies, J-M researchers developed
methods to study the dissolution and breakdown of ﬁbers in vitro
in simulated biological ﬂuids in the absence of cells. The ﬂuids sim-
ulated both lung extracellular ﬂuid and the more acidic intracellu-lar lysosomal environment of alveolar macrophages, which assist
in clearing the lower lung of inhaled debris (Bauer et al., 1994).
The results of these in vitro studies showed reasonably good corre-
lation with the results of the rodent inhalation biopersistence stud-
ies (Table 4). The in vitro ﬁber dissolution studies contributed very
signiﬁcantly to a better understanding of ﬁber biopersistence and
degradation in the lung. However, the results did not correlate as
well to the results of the rodent chronic inhalation carcinogenicity
studies as did the results of the in vivo biopersistence studies.
Chronic exposure to SVFs or any of the ﬁbers with low biopersis-
tence produced neither tumors nor ﬁbrosis in animal inhalation
studies. After the importance of biosolubility was determined, J-
M evaluated each of its ﬁber formulations to determine whether
a more soluble ﬁber composition could be developed while still
meeting the performance requirements of the particular product.
The short-term biopersistence tests, both in vitro and in vivo,
(Bernstein and Riego-Sintes, 1999; Hesterberg et al., 2002) proved
valuable in guiding the development of new ﬁber formulations. For
example, at J-M two new glass ﬁbers were developed for optimal
biosolubility in the lung; J-M 902 for insulation and ﬁltration
use; 481 for ﬁltration use, and J-M 901F for thermal and acoustical
insulation use. All three types of ﬁbers were evaluated for lung
biopersistence and short-term toxicology in rats and for in vitro
dissolution rates. Both types of ﬁbers passed the criteria estab-
lished by The Commission of the European Communities (EU,
1997) that will be discussed later and, thus, do not need to be iden-
tiﬁed as potential carcinogens when sold in the EU market.
5.6. Cell studies (post-1987)
In 1989, J-M began conducting in vitro studies with ﬁbers as
part of its expanded research program. Over the next 8 years, J-M
conducted a series of studies in which various types of cultured
cells were exposed in vitro to the same size-selected manmade
and asbestos ﬁbers that were being tested in the rat and hamster
inhalation studies, as well as to numerous other ﬁber sizes and
compositions (Hart et al., 1994; Hesterberg and Hart, 2001). In
these studies, for all the ﬁber compositions tested, cytoxicity (cell
death or failure to proliferate) and genotoxicity (disruption of the
nuclear material, i.e., the genetic material) were directly propor-
tional to ﬁber number per cell and ﬁber length. The results of these
studies showed that longer ﬁbers were more toxic than shorter ﬁ-
bers, no matter what the composition was of the ﬁbers studied
(Hart et al., 1994). This consistent ﬁnding of cellular effects was
in striking contrast to the results of the chronic rodent inhalation
studies with SVFs. Recall that six of the nine different SVFs studied
did not cause lung ﬁbrosis and seven of the nine synthetic ﬁbers
did not produce an excess of respiratory tract tumors (Table 4).
Since some SVFs were not toxic, even at the MTD, in the chronic
inhalation studies, but all ﬁbers compositions were toxic in the cell
culture studies, it was clear that the in vitro cell culture models
generated false positive results as predictors of in vivo toxicity
and carcinogenicity. Thus, it was reasonable to conclude that the
results of the in vitro assays should not be considered valid for
assessing human health hazards from SVFs (Hesterberg and Hart,
2001). Some scientists have argued that information gained from
in vitro studies with ﬁbers, can provide useful insight into the
mechanisms that cause toxicity and, indeed, tumors. However,
the fact that a mechanistic step is observed in a high dose
in vitro study does not automatically translate to that same mech-
anism occurring in in vivo studies conducted with laboratory ani-
mals at low exposure concentrations.
The biopersistence studies demonstrated that, in the whole ani-
mal, ﬁber dissolution, breakage, and lung clearance remove the
non-biopersistent ﬁber constituents from the lung. This provided
a rational explanation as to why some ﬁber compositions do not
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trations. As with the intra-cavity implantation studies, in vitro cell
culture models do not include the natural deposition and clearance
mechanisms found in intact animals that have been exposed by
inhalation to ﬁbers.6. Critique of intra-cavitary studies
It was not until the 1980s that the experimental approach using
intra-cavity injections began to be critically evaluated. The non-
physiological exposure method differs markedly from the manner
in which people might be exposed in the workplace, which is by
inhalation of airborne ﬁbers. The numerous problems associated
with the non-physiological exposure methods, led many scientists
to conclude later that the results were not appropriate for evaluat-
ing the human health risks of ﬁbrous dusts (Eastes and Hadley,
1994; Collier, 1995; Collier et al., 1995; McClellan et al., 1992;
McClellan and Hesterberg, 1994; McConnell, 1995; Rossiter,
1991). These views were also reﬂected in reviews conducted by
various national and international groups (US Ofﬁce of Science
and Technology Policy (OSTP) 1985, International Program on
Chemical Safety (IPCS, 1988): National Institute for Occupational
Safety and Health (NIOSH, 1977, 1987): the World Health Organi-
zation (WHO, 1992): the National Research Council (NRC, 2000) of
the National Academy of Science: and, the Agency for Toxic Sub-
stance and Disease Registry (ATSDR, 2004). The major concerns
they described were as follows:
(a) Implantation/injection of ﬁbers bypasses the natural defense
mechanisms that are operative with inhaled ﬁbers. For
example, the upper airways naturally ﬁlter out larger ﬁbers
and prevent them from entering the deep lung; lung cells
and mucus efﬁciently remove many of the ﬁbers that are
inhaled and deposited in the airways and in the deep lung.
(b) Very large ﬁbers, which could not normally be inhaled into
the lung, can easily be implanted or injected. Fibers with a
large aerodynamic diameter are non-respirable, which
means they have limited potential for becoming airborne
and remaining suspended in the air and traveling with the
inhaled air into the lower lung. Such non-respirable ﬁbers
are not relevant to the respiratory health of people. How-
ever, these ﬁbers can and often were injected into the body
cavities of laboratory animals.
(c) IP or IT tests typically use very large quantities of ﬁbers such
that a substantial portion of the injected ﬁbers tends to be
concentrated at the injection site. With these large quanti-
ties, ‘‘Normal physiology, homeostasis and detoxiﬁcation or
repair mechanisms may be overwhelmed and cancer, which
otherwise might not have occurred, is induced or promoted’’
(OSTP, 1985).
(d) Target cells for the ﬁbers that are injected or implanted into
the peritoneal abdominal cavity are not the same as for
respiratory tissues that are exposed via inhalation of ﬁbers.
7. Using the new scientiﬁc information
7.1. Equivocal ﬁndings
The results of the chronic inhalation studies with Syrian ham-
sters and rats exposed to high concentrations of MMVF33 ﬁbers
(Special Purpose 475 Glass), manufactured at that time by J-M,
were reported by McConnell et al. (1999). There were no respira-
tory tract tumors observed in the rats that inhaled MMVF33 ﬁbers.
However, a single mesothelioma was observed in one of the 83
Syrian hamsters that were exposed to these same ﬁber prepara-tions. It could be argued that the ﬁnding of a single mesothelioma
was not statistically signiﬁcant. However, J-M elected to take a
more cautious approach and initiate a thorough health risk
assessment.
The MMVF 33 product was manufactured at only one plant.
Company scientists reviewed the worker exposure levels, work
practices and engineering controls and concluded that the existing
1 ﬁber/cc workplace exposure guideline, voluntarily implemented
by J-M, together with a requirement to wear respirators would be
adequately protective of the production workers. J-M also devel-
oped and installed engineering controls to further reduce exposure
levels in the workplace. As an aside, modern ﬁber glass production
facilities are remarkably different than the production facilities
used in the early days of the industry. Increased attention has been
given to ventilation and to the isolation of phases of the production
process that have the highest probability for release of respirable
ﬁbers. Increased automation minimizes the need for production
workers to enter areas with high concentrations of respirable ﬁ-
bers. Not surprisingly, the greatest potential for worker exposure
occurs during maintenance of the production equipment. These
exposures can be avoided by maintenance workers using respira-
tors. In addition to the epidemiology programs, medical monitor-
ing of the workers was increased. This included periodic
pulmonary function testing, lung radiographs and health question-
naires. These data were evaluated on an ongoing basis to comple-
ment the epidemiological studies. Exposure monitoring was also
conducted at customer workplaces to ensure that the recom-
mended 1 ﬁber/cc guideline was consistently met.7.2. Voluntary exposure guidelines
It is worth noting that in the early 1990s, J-M established a vol-
untary workplace exposure guideline of 1 ﬁber/cc for its opera-
tions. A cynical view of such action might be that the company
was seeking to avoid legal liability in light of its adverse asbestos
experience. However, a more balanced view is that it was consis-
tent with J-M’s proactive product stewardship approach. This is
the case since OSHA did not establish the separate personnel expo-
sure limits (PEL) for ﬁber glass, but rather allowed ﬁber glass to be
regulated within the PEL set for nuisance dust (15 mg/m3 total dust
and 5 mg/m3 respirable dust). Since an atmosphere containing
30 mg/m3 ﬁber glass may contain 280 total ﬁbers/cc (Hesterberg
et al., 1993), the OSHA PEL of 5 mg/m3 would roughly equate to
47 ﬁbers/cc. This would be substantially higher than J-M’s volun-
tary workplace guideline.7.3. ACGIH guidance
In 1997, the American Conference of Governmental Industrial
Hygienists (ACGIH), classiﬁed ﬁber glass and mineral wools as
A3, Animal Carcinogen (ACGIH, 1997). The ACGIH found that the
‘‘ﬁbers appear to be carcinogenic only by unusual routes of expo-
sure to test animals (e.g., intrapleural and intraperitoneal injection
and possibly intratracheal injection) that are not considered rele-
vant to worker exposure. Animal inhalation studies of these ﬁbers
have not produced signiﬁcant tumors. Available epidemiologic
studies do not conﬁrm or support an increased risk of cancer in ex-
posed humans. The evidence suggests that the agent is not likely to
cause cancer in humans except under unlikely routes of exposure,
carcinogenic in experimental animals at dose levels, by route(s) of
administration, which are not considered relevant to worker expo-
sure.’’ The ACGIH recommended an exposure limit (threshold limit
value time weighted average, TLV-TWA) of 1 respirable ﬁber/cc for
ﬁber glass and mineral wool. This recommendation was consistent
with the guideline concentration value J-M had established earlier.
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health administration
In 1999, Occupational Safety and Health Administration
(OSHA), trade associations representing US insulation manufactur-
ers, and insulation contractors agreed to a voluntary standard for
exposure to glass ﬁbers. The initial position of the OSHA represen-
tatives was that the permissible exposure limit (PEL) should be
should be set at 0.1 ﬁber/cc (the same as the revised asbestos stan-
dard). However, after discussions and a review of the relevant re-
search, the participants agreed to a voluntary Health and Safety
Partnership Program (HSPP) that included a Voluntary PEL of 1
respirable ﬁber/cc and a commitment from manufacturers to for-
mulate or reformulate ﬁbers with an increased biosolubility as
necessary (NAIMA, 1999). The manufacturers also committed to
monitor occupational exposure to ﬁber glass and as a result built
a database of over 14,000 data points reﬂecting ﬁber concentra-
tions in various ﬁber glass-related job tasks. Charles Jeffress, who
was then Head of OSHA, wrote ‘‘The Health and Safety Partnership
Program provides beneﬁts to workers that even the most tightly
worded regulation may not ensure’’ (OSHA, 1999).8. Carcinogen classiﬁcation based on new scientiﬁc information
Four different organizations took action with regard to the car-
cinogenic classiﬁcation of glass ﬁbers based on the new scientiﬁc
information. This included IARC (2002b), EU (1997), NTP
(2011a,b) and the California Ofﬁce of Environmental Health Hazard
Assessment (2011).8.1. International agency for cancer research re-evaluation (2001–
2002)
In 2001, IARC convened a Panel to reevaluate the carcinogenic
risk of Synthetic Vitreous Fibers, the Working Group’s ﬁndings
were published the following year (IARC, 2002b). Importantly,
the IARC Panel determined that the human epidemiology data for
glass wool, continuous glass ﬁlaments, rock (stone) wool, slag wool
and ceramic ﬁbers were inadequate, i.e., the studies did not pro-
vide evidence of a carcinogenic response. For purposes of hazard
determination, this time the IARC panel decided that the scientiﬁc
evidence was sufﬁcient to differentiate the man-made ﬁbers into
six separate SVF categories (Table 2). The IARC decision to divide
man-made ﬁbers into multiple categories was heavily inﬂuenced
by the large number of well-conducted animal chronic inhalation
carcinogenicity and biopersistence studies that had been spon-
sored by J-M and the rest of the industry between 1987 and
2001 (summarized in Table 4). These studies showed that the bio-
persistent refractory ceramic and special purpose ﬁbers tested
were carcinogenic in animals by inhalation exposure. In contrast,
the less biopersistent insulation glass wool ﬁbers were not carcin-
ogenic. These results were readily explained by differences in the
biopersistence in the lung of these two ﬁber types. The classiﬁca-
tion of the several types of ﬁbers as to carcinogenicity would de-
pend on the results of the animal studies since there was no
epidemiological evidence for any of the ﬁber types having a carcin-
ogenic response, including the durable special purpose ﬁbers.
The 2002 IARC Monograph also made other important changes
in the classiﬁcation of glass wool compared to the 1988 Mono-
graph. These changes resulted primarily because the evidence for
insulation glass wool ﬁbers producing tumors using the intraperi-
toneal (IP) test and other intracavity administrationmethods noted
earlier by IARC (1988) could now be interpreted by considering the
absence of an excess of tumor ﬁndings in well-conducted chronic
inhalation bioassays that had been validated for their ability to de-tect tumor responses elicited by ﬁbers. This resulted in the IARC
Panel concluding there was only ‘‘limited’’ evidence for carcinoge-
nicity of insulation glass wool, rock (stone) wool and slag wool ﬁ-
bers in animals. On the other hand, the new ﬁnding that an excess
of respiratory tract tumors was found in laboratory animals ex-
posed to refractory ceramic and special purpose ﬁbers in well-con-
ducted animal inhalation studies, coupled with the old ﬁnding of
tumors in IP tests could now be viewed as ‘‘sufﬁcient’’ animal evi-
dence for the carcinogenicity of refractory ceramic and special pur-
pose ﬁbers. The 2002 IARC Monograph concluded that insulation
glass wool continuous glass ﬁlaments, rock (stone) wool, and slag
wool ﬁbers were ‘‘not classiﬁable as to their carcinogenicity to hu-
mans (Group 3)’’ (IARC, 2002b). The traditional special purpose ﬁ-
bers and RCF were retained in Group 2B.
It is noteworthy that the IARC Working Group ‘‘elected to not
make an overall evaluation of the newly developed ﬁbers designed
to be less biopersistent such as the alkaline earth silicate or high
alumina, low-silica wools. This decision was made in part because
no human data were available, although such ﬁbers that have been
tested appear to have low carcinogenic potential in experimental
animals, and because the Working Group had difﬁculty categoriz-
ing these ﬁbers into meaningful groups based on chemical compo-
sition.’’ The comment on ‘‘no human data’’ indicates a dilemma
associated with evaluating the carcinogenic hazard of any newly
developed material, there will be no human data because the
material has just entered commerce. Thus, it becomes important
to use the results of short-term tests such as the biopersistence
tests described earlier and traditional two-year bioassays, as pre-
dictors of the likelihood or lack of likelihood that a newly devel-
oped material has carcinogenic properties. This situation will be
discussed in greater detail later.
The designation of the four ﬁber types as Group 3 –, ‘‘not clas-
siﬁable as to carcinogenicity to human,’’ deserves further com-
ment. Presumably, these ﬁbers could have been considered for
placement in Group 4 – ‘‘probably not carcinogenic to humans.’’
It is noteworthy that since the beginning of the Monograph Pro-
gram, IARC panels have placed only a single compound, Caprolac-
tam, a chemical used in producing nylon, in this group (IARC,
1979). This use of the Group 4 classiﬁcation occurred in the early
days of the IARC Monograph Program. This can be interpreted as
illustrating the reluctance of IARC Panels to use the Group 4 classi-
ﬁcation even in the face of negative data as to carcinogenicity of a
particular substance.
8.2. European Commission’s Directive on synthetic mineral ﬁbers
The European Commission regulates hazardous chemicals un-
der the Directive for Classiﬁcation and Labeling of Dangerous Sub-
stances (Council Directive 67/548/EEC). Directive 97/69/EC,
speciﬁcally addressing synthetic ﬁbers, was enacted on the 5
December 1997 which adopted ‘for technical progress’ the Danger-
ous Substances Directive (EU, 1997; Bernstein, 2007).
Following IARCs initial classiﬁcation in 1988 and the review of
synthetic mineral ﬁbers by the WHO International Program on
Chemical Safety in 1988, the European commission initiated steps
for the classiﬁcation of synthetic mineral ﬁbers. Working with
industry initial proposals for classiﬁcation schemes were submit-
ted to the Commission in 1989. Discussion of alternative classiﬁca-
tion schemes continued in the early 1990s, however, no agreement
on a classiﬁcation scheme.
In 1996, a meeting was convened by the EC to discuss the scien-
tiﬁc basis that could be used for establishing a synthetic mineral ﬁ-
ber directive. At that meeting the chronic inhalation and
intraperitoneal injection studies and their relationship with the ﬁ-
ber biopersistence studies presented in this paper were discussed.
This led to a mandate by the EC to convene an Expert Working
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biopersistence to the chronic study results. As part of this mandate
a ‘call for data’ was issued requesting as much as possible the ori-
ginal data ﬁles for the various studies. These data were used to
independently evaluate the results from the different types of
studies.
The expert group found that:
The inhalation and intratracheal instillation biopersistence T1/2
(half-life in the lung) of Fibers L > 20 lm was found to correlate
with: (a) number of ﬁbers L > 20 lm remaining after 24 months
exposure in the chronic inhalation studies; (b) early pulmonary
ﬁbrosis in the chronic inhalation studies, and (c) number of tumors
in the IP studies when ﬁber length and number ﬁbers injected are
taken into account.
These results became the basis for the synthetic mineral ﬁber
Commission Directive 97/69/EC of 5 December 1997 (Adopting
for technical progress for the 23rd time Council Directive 67/548/
EEC, classiﬁcation and labeling of dangerous substances). The sci-
entiﬁc results that served as the basis of the Directive were subse-
quently published (Bernstein et al., 2001a, 2001b).
The European Commission (EU, 1997), adopted a formal direc-
tive for not classifying certain ﬁbers as a carcinogen if they met cer-
tain criteria or, as some have called it, an exoneration process.
Speciﬁcally, ‘‘The classiﬁcation as a carcinogen need not apply if
it can be shown the substance fulﬁlls one of the following
conditions:
– a short-term biopersistence test by inhalation has shown the
ﬁbers longer than 20 lm have a weighted half life less than
10 days, or
– a short-term biopersistence test by intratracheal instillation has
shown that the ﬁbers longer than 20 lm have a weighted half-
time less than 40 days, or
– an appropriate intra-peritoneal test has shown no evidence of
excess carcinogenicity, or
– absence of relevant pathogenicity or neoplastic change in a suit-
able long-term inhalation test.’’
The adoption of this formal directive served as a major stimulus
to European Synthetic Fiber Manufacturers developing, testing
and, then, marketing synthetic glass ﬁbers that had low biopersis-
tence and could meet the criterion for exoneration from identiﬁca-
tion as a carcinogen in the absence of data from chronic bioassays.
The development of a regulatory paradigm that avoided the need
for conducting long-term studies utilizing large numbers of ani-
mals was also consistent with a growing movement around the
world to minimize the number of laboratory animals used in re-
search. No doubt, the European Commission (EU, 1997) Directive
also inﬂuenced the manufacture and marketing of low biopersis-
tence, and hence, safer ﬁbers, in other markets around the world.
8.3. National Toxicology Program 12th report on carcinogens
In view of the substantial body of new science and the action of
IARC (2002b) on that science, the North American Insulation Man-
ufacturers Association in 2002 (Hadley and Mentzer, 2004) re-
quested that the National Toxicology Program, as it began
preparing the 12th RoC, re-evaluate its listing of ‘‘Glass Wool
(Respirable Size) as ‘‘reasonably anticipated to be a human carcin-
ogen.’’ This listing was ﬁrst published in the 7th Report on Carcin-
ogens (NTP, 1994) and remained unchanged in each report through
the 11th Report on Carcinogens (NTP, 2004). Unifax (Carey, 2004),
a manufacturer of refractory ceramic ﬁbers endorsed the need for
re-evaluation of the listings for vitreous synthetic ﬁbers.
The preparation of the 12th Report on Carcinogens extended
over a number of years and was ﬁnally concluded when the reportwas released on June 10, 2011 (NTP, 2011a,b). It is beyond the
scope of this paper to review all of the details of the NTP re-
evaluation process for glass wool ﬁbers, however, key aspects of
the process will be brieﬂy described. Detailed information, includ-
ing various reports cited later, can be found on the NTP website.
In accord with the announced NTP process (NTP, 2009a), a draft
background document was prepared and released for public com-
ment —‘‘DRAFT, Report on Carcinogens Background Document for
Glass Wool Fiber’’ (NTP, 2009b). The draft document was prepared
by SRA International, Inc. under an NIEHS Contract. Subsequent to
release of the draft document, Hadley (2010a) provided complete
documentation for a study of glass ﬁbers conducted many years
earlier for the National Institute for Occupational Safety and Health
at Battelle Memorial Institute, Columbus (Mitchell et al., 1982).
This study had been reported in summary form in the open litera-
ture by Mitchell et al. (1986) and Moorman et al. (1988), reports
cited in the draft substance proﬁle.
A number of commentswere submitted to the NTP critiquing the
draft backgrounddocument (Bauer, 2009; Crane, 2009a; Donaldson,
2009; Hadley, 2009; Hesterberg, 2009; Marsh et al., 2009; Mentzer,
2009; Ray and Bauer, 2009). These comments summarized more
than two decades of research and hundreds of peer-reviewed publi-
cations, largely sponsored by the glass ﬁber industry.
The NTP’s review process for preparation of the 12th RoC calls
for the use of an Expert Panel to provide scientiﬁc advice on the
listing (or de-listing) of each of the substances under consideration
for listing in the Report (Fig. 1). The NTP appointed to the Glass
Wool Fibers Expert Panel nine highly qualiﬁed scientists with
recognized expertise in aerosol science, inhalation toxicology,
industrial hygiene, pulmonary medicine, pulmonary biology/
pathobiology and hazard evaluation. The NTP Expert Panel was
charged (1) to apply the RoC listing criteria to the relevant scien-
tiﬁc information and make recommendations regarding its listing
status (i.e., known to be a human carcinogen, reasonably antici-
pated to be a human carcinogen or to not list) in the 12th RoC,
and (2) to provide a scientiﬁc justiﬁcation for the recommendation
(NTP, 2009b). The Expert Panel received the draft background doc-
ument in advance of its meeting.
The Glass Wool Fibers Expert Panel, at its meeting on June 9–10,
2009, heard oral presentations from many of the individuals who
had offered written comments to the NTP on the draft background
document. Undoubtedly, the individual members of the NTP Expert
Panel were also knowledgeable of the IARC (2002b) Monograph
that provided scientiﬁc documentation for most recent IARC sepa-
rate evaluation of man-made ﬁbers.
The peer review ﬁndings and listing status recommendations of
the Expert Panel were contained in two reports, Part A and B
(Kelsey, 2009a,b). The recommendations of the NTP Glass Wool
Fibers Expert Panel with regard to the listing (de-listing) of glass
ﬁbers were clear and unambiguous.
 The Expert Panel, by a vote of 8 Yes and 0 No, recommended
‘‘that glass wool ﬁbers, with the exception of special ﬁbers of
concern (characterized physically below), should not be classi-
ﬁed either as known to be a human carcinogen or reasonably
anticipated to be a human carcinogen.’’
 The NTP Expert Panel also recommended by a vote of 7 yes, 0 no
and 1 abstention, ‘‘based on sufﬁcient evidence of carcinogenic-
ity in well-conducted animal inhalation studies, that special
purpose glass ﬁbers with the physical characteristics as follows
– longer, thinner, less soluble ﬁbers (for example, P15 lm
length with a Kdis of 6100 ng/cm2/h) – reasonably anticipated
to be human carcinogens for the listing status in the RoC.’’
By offering two separate and distinct recommendations based
on scientiﬁc evidence, the NTP Expert Panel was making a strong
272 T.W. Hesterberg et al. / Regulatory Toxicology and Pharmacology 62 (2012) 257–277statement that it was scientiﬁcally inappropriate to continue the
practice of lumping all glass ﬁbers together within a single listing
for human carcinogenicity as originally done in the 7th RoC and
continued through the 11th RoC. The NTP Glass Wool Fibers Expert
Panel clearly expressed a scientiﬁc opinion that the physical prop-
erties and related carcinogenic effects in laboratory animals for
certain synthetic ﬁbers warranted listing these ﬁbers as ‘‘reason-
ably anticipated to be human carcinogens.’’ It is equally clear the
NTP Glass Wool Fibers Expert Panel was of the opinion that scien-
tiﬁc evidence did not support listing less biopersistent glass wool
ﬁbers as ‘‘reasonably anticipated to be a human carcinogen.’’
The recommendations of the Glass Wool Fibers Expert Panel
were subsequently published in the Federal Register with a request
for public comments (NTP, August 12, 2009). At least three letters
were submitted to the NTP supporting the recommendations of the
NTP Expert Panel (Crane, 2009b; Ray and Baure, 2009; Venturin,
2009).
Following receipt of the Expert Panel’s Reports (Kelsey, 2009a,b),
the NTP presumably convened two separate Working Groups to
meet in closed sessions to recommend listing status for the candi-
date substance as described in the RoC review process (NTP,
2009a). The membership and the deliberations of these two Groups
(the Interagency Scientiﬁc Review Group and the NIEHS/NTP Scien-
tiﬁc Review Group) have not beenmade public. As an aside, the RoC
review process in the future could be improved by having these
Working Groups meet in public sessions so the total process will
be more open and transparent. Although the details are not known,
the ‘‘DRAFT, Report on Carcinogens Background Document for Glass
Wool Fibers’’ (NTP, 2009b)was transformed into a seconddocument
– ‘‘DRAFT Report on Carcinogens Substances Proﬁle for Glass Wool
Fibers (Respirable) as a Class (NTP, 2011a,b).
The Draft Substance Proﬁle contained a single preliminary rec-
ommendation – ‘‘Glass Wool Fibers (Respirable) as a Class, CAS No.
None Assigned, Presumably anticipated to be a human carcinogen,
ﬁrst listed in the Seventh Report on Carcinogens (1994).’’ This rec-
ommendation appeared to be at complete odds with the recom-
mendations of the Glass Wool Fibers Expert Panel (Kelsey,
2009a,b) and public commentors.
The NTP Board of Scientiﬁc Counselors (BSC) discussed the ‘‘Re-
port on Carcinogens Substance Proﬁle for Glass Wool Fibers (Respi-
rable) as a Class’’ at a meeting on June 21, 2010. The Board was
provided oral and written comments by representatives of the ﬁber
glass industry (Donaldson, 2010; McClellan and Hahn, 2010;
Hesterberg, 2010; Crane, 2010a,b, and Hadley, 2010b; Ray, 2010).
The commentors succinctly reviewed the scientiﬁc evidence consid-
eredby IARC (2002b)whichprovideda separate evaluationand clas-
siﬁcation of the several types of man-made ﬁbers. They also
summarized the NTP Glass Wool Fibers Expert Panel recommenda-
tions (Kelsey, 2009a,b) and the science that informed that Panel’s
recommendations for listing as ‘‘reasonably anticipated’’ only spe-
cial ﬁbers of concern. Basically, the commentors endorsed the sci-
ence-based recommendations of the NTP Glass Wool Fibers Expert
Panel and urged the NTP to follow the scientiﬁcally sound advice
of its Expert Panel and to proceed expeditiously with preparation
of the 12th Report on Carcinogens. The members of the BSC offered
comments which are recorded in the minutes of the meeting.
On June 10, 2011, the NTP formally released the 12th RoC (NTP,
2011a,b). It contained the entry – ‘‘Certain Glass Wool Fibers (Inha-
lable), CAS No: none assigned, Reasonably anticipated to be a hu-
man carcinogen.’’
The word ‘‘Certain’’ in ‘‘Certain Glass Wool Fibers (Inhalable)’’ is
deﬁned by the phrase in the opening paragraph of the supporting
documentation – ‘‘only certain ﬁbers within this class – speciﬁcally
ﬁbers that are biopersistent in the lung or tracheobronchial region
– are reasonably anticipated to be human carcinogens.’’ It is inferred
from the language of the documentation and the NTP mediarelease and questions and answers that the NTP views biopersis-
tent glass ﬁbers to be ‘‘reasonably anticipated to be a human car-
cinogen’’ and more soluble and, hence, less biopersistent glass
ﬁbers that have been assessed in animal studies to not be of equiv-
alent concern with regard to carcinogenic hazard.
This position is consistent with the recommendations of the
NTP Glass Wool Fiber Expert Panel on the importance that ﬁber
biopersistence plays in hazard determination but different from
the Expert Panel’s data sources needed to determine that biopersis-
tence. Thus, while the Expert Panel considered in vitro data to as an
appropriate surrogate for biopersistence, the NTP in the 12th RoC
ultimately rejected in vitro data instead looked to animal assess-
ments – in vivo data – to determine biopersistence and hence haz-
ard. Based on the 12th RoC documentation and the Expert Panel’s
recommendations used to support the ﬁber glass listing, it would
appear that the adjective – ‘‘Certain’’ refers to – ‘‘Inhalable Bioper-
sistent Glass Fibers.’’ For clarity, it would have been helpful if the
12th RoC had explicitly stated – ‘‘Less Biopersistent Glass Fibers’’
are not listed as ‘‘reasonably anticipated to be a human carcinogen’’
or ‘‘a human carcinogen’’ in keeping with the recommendation of
the Expert Panel.
The shift from the use of ‘‘respirable’’ to ‘‘inhalable’’ deserves dis-
cussion. This is a subtle change likely to be of little consequence for
any speciﬁc glass ﬁbers with regard to its inclusion or exclusion un-
der the descriptor – ‘‘Certain Glass Wool Fibers.’’ The terms are rel-
evant in describing qualitative differences in the likelihood of
ﬁbers reaching various compartments of the respiratory tract. It is
important to recognize thatneither term, respirableor inhalable, ad-
dresses the solubility and, hence, the biopersistent of glass ﬁbers.
The American Conference on Governmental Industrial Hygienists
(ACGIH)providedoneof theearliest andclearestdescriptionof inha-
lable versus respirable particles consistent with recognition that ﬁ-
bers are a special kind of particle (ACGIH 1997, 2011). Inhalable
Particulate Matter, characterized as to their aerodynamic diameter,
is used for those ‘‘materials that are hazardouswhen deposited any-
where in the respiratory tract.’’ In contrast, respirable particulate
matter, is used ‘‘for thosematerials that are hazardouswhen depos-
ited in the gas-exchange region.’’ In reality, all inhalable particles in-
clude a respirable fraction and rarely is an aerosol characterized as
inhalable free of respirable particles. Thus, neither the use of ‘‘respi-
rable’’ or ‘‘inhalable’’ is particularly constraining on ﬁbers covered
with the descriptor – ‘‘Certain Glass Wool Fibers.’’
8.4. California Ofﬁce of Environmental Health Hazard Assessment
It is noteworthy that the California Ofﬁce of Environmental
Health Hazard Assessment (OEHHA) published on November 18,
2011, a Notice of Modiﬁcation of the Listing of Glasswool Fibers
(Airborne Particles of Respirable Size) to ‘‘Glass Wool Fibers (Inha-
lable and Biopersistent)’’ OEHHA in 1990 had listed ‘‘glass wool ﬁ-
bers (airborne particles of respirable size) as known to the State to
cause cancer via the authoritative bodies listing mechanism.’’ This
determination was based on the IARC (1988) monograph. This list-
ing was further substantiated by the Seventh Annual Report on
Carcinogens (NTP, 1994) listing of ‘‘glass wool (respirable size) as
reasonably anticipated to be a human carcinogen. The 12th Report
on Carcinogens (NTP, 2011a,b) listing of ‘‘Certain Glass Wool Fibers
(Inhalable) as reasonably anticipated to be carcinogenic to hu-
mans’’ prompted the California OEHAA to modify its listing. Effec-
tive November 18, 2011, the listing is ‘‘Glass Wool ﬁbers (inhalable
and biopersistent).’’ The speciﬁc inclusion of ‘‘biopersistent’’ in the
listing language, along with ‘‘inhalable,’’ provides a very explicit
and concise statement that is consistent with the scientiﬁc evi-
dence. Most notably, it is less ambiguous than the NTP listing that
did not clearly identify biopersistence as being crucial in determin-
ing the carcinogenic potential of glass wool ﬁbers.
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It is of interest to consider the NTP’s actions with regard to the
classiﬁcation of ‘‘Certain Glass Wool Fibers (Inhalable)’’ within the
broader context of NTP’s future actions classifying other ‘‘green
products and technologies.’’ Here we use the term ‘‘green products
or technologies’’ as an umbrella term for new products or technol-
ogies that are intended to have reduced impact on the environ-
ment and human health’’ as compared to the product or
technology being replaced or reduced in use.
These ‘‘green products or technologies,’’ including newly
developed low biopersistent glass wool ﬁbers, pose a special chal-
lenge for those charged with classifying a new substance as to its
potential human health hazards including carcinogenicity. At the
outset, it is important to recognize that evaluating the hazard of a
new product or technology is very different than evaluating a
speciﬁc chemical. A chemical is the same at all times, benzene
or formaldehyde today is the same as the chemical was a decade
or a century ago. The uses of a chemical may change over time
but its basic physical properties do not change. Knowledge of
the hazard of the chemical may change over time as a result
of additional research and advances in science. Thus, evidence
of the potential hazard of the chemical is germane whether it
was obtained last year or a half century ago. That is not true
for a product or technology that has been purposefully changed.
It is apparent in developing the 12th RoC listing for glass ﬁbers,
the NTP struggled with differentiating between information
gained from studies conducted decades ago with old materials
versus that obtained on contemporary materials.
As an aside, the RoC listings published to date have dealt almost
exclusively with speciﬁc chemicals. Of 54 Substances listed in the
12th RoC as ‘‘Known to be Human Carcinogens’’ only a few are not
speciﬁc chemicals and, thus, have the potential to change with
new technological developments. Of the 188 Substances listed in
the 12th RoC as ‘‘reasonably anticipated to be a human carcinogen’’
only three substances are likely to have their principal characteris-
tics changed as a result of purposeful new technological advances:
(a) Ceramic Fibers (Respirable Size), (b) Diesel Exhaust Particulates
and (c) Certain Glass Wool Fibers (Inhalable). The development of
safer glass ﬁbers has been addressed in this paper. Ceramic ﬁbers
without carcinogenic properties have already been developed. Rev-
olutionary technological changes have been made in diesel engines
such that with use of ultra-low sulfur fuels and exhaust after treat-
ment emissions from New Technology Diesel Engines are less than
1% of the emissions of Tradition Diesel Engines (Hesterberg et al.,
2011).
A second issue was noted by the IARC Working Group (IARC,
2002a) for the less biopersistent glass wool ﬁbers, ‘‘no human data
were available.’’ The newly developed products have been pro-
duced and on the market for only a few years. Thus, epidemiolog-
ical studies focusing on late-occurring diseases such as cancer of
production workers or users of the new products are not feasible
soon after a product has been introduced. Even with the passage
of time, such studies are not likely to be conducted if the product
is viewed as having a low hazard potential. Grandjean et al.
(2011), based on a review of over 100,000 journal articles pub-
lished in 2000–2009, noted that ‘‘the persistence of some environ-
mental chemicals in the scientiﬁc literature may be due to a
‘‘Mathew’’ principle of maintaining prominence for the very reason
of having been well researched.’’ It follows then that research will
continue to be performed on well-studied Traditional Diesel Ex-
haust with limited studies conducted on New Technology Diesel
Exhaust. The low likelihood of detecting positive effects in studies
with New Technology Diesel Exhaust is likely to serve as a detri-
ment to conducting such studies.The absence of human evidence for a new ‘‘green product or
technology’’ places a premium on the development of other data
that may be predictive of hazard potential. The short-term
in vitro and in vivo biopersistence studies for glass ﬁbers provide
that kind of predictive information. The Glass Wool Fiber Expert
Panel (Kelsey et al., 2009a,b) recognized that with their recommen-
dations. The 12th RoC documentation (NTP, 2011a,b) for ‘‘Certain
Glass Wool Fibers (Inhalable)’’ contains the statement – ‘‘Because
there is considerable variation in the physiochemical and biologi-
cal properties of individual glass wool ﬁbers, carcinogenic potential
must be assessed on a case-by-case basis in experimental animals,
through either long-term carcinogenicity assays, or assays measur-
ing the persistence of ﬁbers in the lung.’’ This statement is essen-
tially an endorsement of the predictive capability of the short-
term biopersistence assays for characterizing synthetic vitreous ﬁ-
bers as to their carcinogenic potential, an approach that reduces
the need to conduct laboratory animal studies. As already noted,
animal carcinogenicity bioassays are expensive, time consuming
and required the use of large numbers of laboratory animals.10. Summary and conclusions
This paper has reviewed a proactive product stewardship ap-
proach developed by J-M,working in partnershipwith other glass ﬁ-
ber manufacturers, in response to the product liability crisis that
arose overwhether glass ﬁberswould be the next asbestos. A central
component of the approach was an extensive testing and research
programtoassure thatﬁber glass productswere safe tomanufacture
and use. As of themid 1980s, the state of the science in ﬁber toxicol-
ogy was not well developed. Different approaches used to evaluate
the toxicity of ﬁbers produced seemingly contradictory results. A
comprehensive, systematic and scientiﬁc approach was needed. J-
M, in cooperation with other manufacturers of ﬁber glass designed,
contracted for, and in some cases, directly conducted epidemiologi-
cal studies, animal toxicology investigations and in vitro studies. The
epidemiology studies included production and maintenance work-
ers at 17 of the oldest and largest ﬁber glass andmineral wool man-
ufacturing facilities in the United States. Those studies reafﬁrmed
the lack of association between exposure to glass wool ﬁbers and
respiratory tract cancer.
There were numerous difﬁculties interpreting the results of
early research on glass ﬁbers and other inorganic ﬁbers conducted
in laboratory animals. As noted, these studies often used non-phys-
iological exposure routes such as intraperitoneal, intrapleural, or
intratracheal injection of massive quantities of ﬁbers. New studies
were designed and conducted that systematically addressed these
limitations and provided data that was more relevant for assessing
the potential human health hazards of exposure to airborne ﬁbers.
The chronic inhalation exposure studies conducted in rats and Syr-
ian hamsters demonstrated that biopersistence was the key deter-
minant of the toxicity and carcinogenicity of synthetic vitreous
ﬁbers. As expected, Amosite and Crocidolite Asbestos, which were
very persistent in the lungs, produced lung ﬁbrosis and tumors.
Glass wool, Rock (Stone) Wool and Slag Wool Fibers, which had
low biopersistence in the lungs did not cause lung ﬁbrosis or tu-
mors, while the more durable and biopersistent man-made ﬁbers
(an industrial refractory ceramic ﬁber and a special purpose ﬁber)
caused increased incidences of ﬁbrosis and tumors. Fiber clearance
rates determined from short-term inhalation studies were found to
correlate very well with ﬁber induced pathology with biopersistent
ﬁbers producing pathological changes in the respiratory tract. An
understanding of the determinants of toxicity and carcinogenicity
has provided a scientiﬁc basis for developing and introducing
new safer ﬁber glass products. The availability of short-term test
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opment of safer new glass ﬁbers.
An important ﬁnding was that the results of in vitro cell culture
studies were not predictive of the ﬁbrosis and tumor induction ob-
served in the chronic rodent inhalation studies with less biopersis-
tent ﬁbers. This evaluation indicated that the in vitro cell culture
models generated false positive results presumably related to the
large doses of ﬁbers used in the assays. It is clear that the results
of past cell culture studies with large doses of ﬁbers should not
be considered valid for assessing human health hazards, and most
certainly not risks, from SVFs. In contrast, the results of in vitro ﬁ-
ber dissolution studies which measure ﬁber dissolution and break-
age in simulated biological ﬂuids in the absence of cells were good
predictors of the in vivo fate of ﬁbers in the rodent inhalation biop-
ersistence studies and the occurrence of ﬁbrosis and tumors.
The experience with synthetic ﬁbers provides important per-
spective for the growing enthusiasm for using short-term test
methods based on modern biology to evaluate the potential toxic-
ity of chemicals and other agents (NRC, 2007). At least two impor-
tant lessons emerge from the synthetic ﬁber experience. First,
realistic doses of ﬁbers that can be linked to realistic exposure con-
ditions must be selected for evaluation in in vitro assays. Unrealis-
tic doses administered to cells can yield results that on superﬁcial
examination appear mechanistically plausible. The development of
mechanistic data with high levels of in vitro exposure does not nec-
essarily mean the observed mechanisms are likely to occur with
lower levels of exposure and tissue doses likely to be encountered
by workers or the general public. Second, it is important that tests,
whether they be in vitro assays such as those used to evaluate
mutagenicity, short-term animal tests to evaluate biopersistence
or chronic animal bioassays to evaluate carcinogenicity, need to
be evaluated for their predictive capability using both materials
known to be human toxicants and materials demonstrated to have
an absence of human toxicity. In the case of asbestos and other ﬁ-
bers, the endpoint of concern was the potential for inducing respi-
ratory tract cancer. A large body of evidence clearly indicated
certain kinds of asbestos are carcinogenic to humans. For certain
kinds of SVFs, a convincing body of epidemiological evidence was
available showing that exposure to glass ﬁbers do not have an
associated increase in respiratory tract cancers. This human data,
both positive and negative, were of immense importance in vali-
dating the predictive capability of the chronic inhalation bioassay
protocol and the short-term biopersistence protocol. Most impor-
tantly, it is now clear that what once were thought to be biologi-
cally plausible predictions of human hazards for glass ﬁbers were
not valid.
By the turn of the 21st century, the state of the science in ﬁber
toxicology had progressed from a tangle of contradictory theories
to clear understanding of the behavior of ﬁbers in the lung. In vitro
studies, and even chemistry models based on those studies, can
now be used to predict the biopersistence of ﬁbers in well-de-
signed and well-conducted animal studies. Most importantly,
these advances in the science provide a basis for understanding
which synthetic ﬁbers have the potential for producing disease
or mortality and conversely, the ﬁbers with limited hazard
potential.
One result of this proactive product stewardship approach to
sponsoring scientiﬁc research that yielded new information on
the potential health effects of SVFs was the reclassiﬁcation by IARC
of Glass Wool, Rock (Stone) Wool and Slag Wool ﬁbers from ‘‘pos-
sibly carcinogenic to humans (Group 2B) to ‘‘not classiﬁable as to
their carcinogenicity to humans (Group 3).’’ The National Toxicol-
ogy Program’s Report on Carcinogens, used the same extensive
body of information to conclude – ‘‘Certain Glass Wool Fibers
(Inhalable)’’ – ‘‘reasonably anticipated to be a human carcinogen.’’
In our view, the descriptor – ‘‘Certain Glass Wool Fibers (Inhala-ble)’’ may be viewed as equivalent to ‘‘Inhalable Biopersistent Glass
Fibers’’ with purposeful exclusion of biosoluble and, thus, less bio-
persistent, glass ﬁbers. This approach is consistent with the Califor-
nia OEHHA approach of listing ‘‘Glass Wool Fibers (Inhalable and
Biopersistent)’’ ‘‘as reasonably anticipated to be a human
carcinogen.’’
The most signiﬁcant outcome of this substantial product stew-
ardship effort is that industry has used the research results to
guide changes in the composition of ﬁbers and the manufacturing
process. This has resulted in glass ﬁber products marketed today
that are even less biopersistent than earlier ﬁber glass product, if
inhaled, and, thus, can be viewed as safer. Public conﬁdence in
the safety of ﬁber glass used as an insulating material is especially
important in today’s economy that emphasizes energy efﬁciency.11. Dedication – Dr. Paul Kotin
The authors dedicate this manuscript to the memory of Dr. Paul
Kotin (1917–2008). Dr. Kotin was a pioneer in the ﬁeld of occupa-
tional and environmental health. He received his M.D. from the
University of Illinois in 1939. After completing a residency in
Pathology at Deaconess Hospital in Chicago, he served in the US
Army Medical Corps from 1941 to 1946 followed by several years
of private practice. In 1948, he joined the faculty of the University
of Southern California. In 1962, he moved his research program on
the health effects of air pollution from the University of Southern
California to the National Cancer Institute in Bethesda, MD. Kotin
was to ultimately serve as Scientiﬁc Director for Etiology, National
Cancer Institute. In that role he was a visionary as evidenced by a
letter he wrote to Mary W. Lasker, Albert and Mary Lasker Founda-
tion, following a meeting with her concerning research on carcino-
genesis. He wrote on April l8, 1966 – ‘‘Attached is a brief
description of six research activities which I believe are ready for
exploitation. You will note that they are directed to and primarily
emphasize the use of human populations for the study of cancer in
man with appropriate supporting laboratory-experimental studies.
I believe that recent advances in both areas have provided a ﬁrm
base for expansion of research in which both approaches can be
simultaneously pursued in a cooperative and complementary man-
ner. This inter-digitation of the experimental laboratory and the
human population laboratory to the end of increasing the effective-
ness of our cancer control efforts offer hope of signiﬁcantly short-
ening the time when we may see demonstrable beneﬁts as
measured by improved morbidity and mortality data.’’ The letter
and attachment is available on-line within ‘‘The Mary Lasker pa-
pers, Proﬁles in Science, National Library of Medicine.’’ The vision
he outlined in 1966 remains appropriate today. Ironically, in that
letter one of the populations he identiﬁes as needing further study
are those engaged in ‘‘asbestos mining and use.’’ In his 1966 letter,
he suggested a need for additional funds of $9 million in 1967
growing to $25 million in 1970. In November 1966, he was named
as Head of what was then called the National Institutes of Health
(NIH) Division of Environmental Health Sciences. In 1969, the Divi-
sion became the nucleus of the National Institute for Environmen-
tal Health Sciences, the ninth NIH Institute with an initial budget of
$17.8 million. Kotin was named the Institute’s ﬁrst Director.
In 1971, he became Dean of the School of Medicine, Vice Presi-
dent for Health Science and Provost at Temple University, Philadel-
phia, PA where he had substantial impact on that institution’s
Medical School.
In 1974, Kotin joined J-M as Senior Vice President for Health,
Safety and Environment. Kotin was with J-M during the difﬁcult
time period when the asbestos issue came to the forefront and
forced J-M into bankruptcy. He recognized the importance of J-M
emerging from bankruptcy as a viable corporation if it was going
T.W. Hesterberg et al. / Regulatory Toxicology and Pharmacology 62 (2012) 257–277 275to provide ﬁnancial compensation to individuals who had asbestos
exposure-related diseases. This, in turn, led to his fervent support
of the research program to ensure that the ﬁber glass products
manufactured and marketed by J-M were safe. It is not surprising
that the J-M research program on glass ﬁbers fostered by Kotin in-
cluded both human population and laboratory-experimental stud-
ies with both kinds of studies simultaneously pursued in a
cooperative and complementary manner. The continued availabil-
ity of safe ﬁber glass products for use around the world is a tribute
to the vision of Paul Kotin.
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